Pneumonia, organism unspecified

J10_PNEUMONAS

pneumonia: An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, caused by an infection in one or both of the lungs (by bacteria, viruses, fungi, or mycoplasma.). Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J18 Hospital discharge: ICD-9 — 485 Hospital discharge: ICD-8 — 4850[2-9]\|486 Cause of death: ICD-10 — J18 Cause of death: ICD-9 — 485 Cause of death: ICD-8 — 4850[2-9]\|486 2 out of 7 registries used, show all original rules.	69647
4. Check minimum number of events None	69647
5. Include endpoints None	69647
6. Filter based on genotype QC (FinnGen only)	69647

Control definitions (FinnGen only)

Control exclude: J10_INFLUPNEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J09-J18
Name in latin: Pneumonia ab organismo non specificato

NAME	J10_PNEUMONAS
CONTROL_EXCLUDE	J10_INFLUPNEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J18
HD_ICD_9	485
HD_ICD_8	4850[2-9]\|486
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J18
COD_ICD_9	485
COD_ICD_8	4850[2-9]\|486
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pneumonia, organism unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Lung transplantation

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	69647	29145	40502
Unadjusted period prevalence (%)	14.54	9.93	17.86
Median age at first event (years)	64.63	59.52	68.30

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
34573: Matched controls
283938

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.3

323.0

5047

10881

A46

ICD-10 Finland

Erysipelas

2.5

323.0

4217

14973

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

11.7

323.0

1705

1248

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

323.0

3233

10702

J01CA04

ATC

amoxicillin; systemic

1.9

323.0

28015

198070

J45.9

ICD-10 Finland

Asthma, unspecified

2.8

323.0

7115

24019

I50.9

ICD-10 Finland

Heart failure, unspecified

5.2

323.0

3123

5284

J47

ICD-10 Finland

Bronchiectasis

9.4

323.0

760

677

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

323.0

5396

18508

WX892

NOMESCO Finland

Monitored bed care

3.3

323.0

2739

7185

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.9

323.0

2300

4085

L28

ICPC

Limited function/disability (L)

2.2

323.0

3997

15794

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

299.8

323.0

578

R06.0

ICD-10 Finland

Dyspnoea

2.5

323.0

8460

32837

Z3226

NOMESCO Finland

Physiotherapist

1.9

323.0

5959

27790

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.1

323.0

1533

3213

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

323.0

7442

28460

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

35.5

323.0

507

119

J01FF01

ATC

clindamycin; systemic

1.9

323.0

9168

46183

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.2

323.0

3576

7503

N05BA01

ATC

diazepam; systemic, rectal

2.2

323.0

4509

18159

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.5

323.0

4623

7751

A06AD11

ATC

lactulose; oral

2.6

323.0

3777

12700

N02BE01

ATC

paracetamol; systemic, rectal

1.8

323.0

28148

200848

N05AA02

ATC

levomepromazine; systemic

3.9

323.0

1846

4043

J45.1

ICD-10 Finland

Nonallergic asthma

3.1

323.0

2714

7639

R4110

NOMESCO Finland

Physiotherapy

1.8

323.0

8525

42913

D64.9

ICD-10 Finland

Anaemia, unspecified

2.8

323.0

2440

7584

A02BC02

ATC

pantoprazole; systemic

1.7

323.0

20683

131048

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.2

323.0

1238

2030

R03BB04

ATC

tiotropium bromide; inhalant

4.7

323.0

3753

7159

N02AX02

ATC

tramadol; systemic, rectal

1.8

323.0

13266

74199

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.7

323.0

5044

16908

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.5

323.0

3409

11964

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

83.7

323.0

5673

665

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

323.0

18556

109419

J46

ICD-10 Finland

Status asthmaticus

5.6

323.0

1226

1849

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

323.0

6114

27024

GD1AD

NOMESCO Finland

Thorax CT examination

4.6

323.0

1710

3179

I50.0

ICD-10 Finland

Congestive heart failure

6.0

323.0

1432

2023

J18.9

ICD-10 Finland

Pneumonia, unspecified

206.3

323.0

28266

6070

J01DB01

ATC

cefalexin; oral

1.8

323.0

27639

196502

N02AA05

ATC

oxycodone; systemic

3.3

323.0

4753

13205

N05CD07

ATC

temazepam; oral

2.4

323.0

3439

12356

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.6

323.0

1889

4436

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

323.0

9587

47682

N05CF01

ATC

zopiclone; oral

1.8

323.0

9543

49814

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.6

323.0

3061

10191

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.5

323.0

3474

6910

48609

ICD-8 Finland

Pneumonia, unspecified

+∞

323.0

2395

SPAT1255

SPAT

Intravenous administration of medicine

3.2

323.0

2308

6301

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.9

323.0

2278

4015

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

323.0

5638

26113

J01MA02

ATC

ciprofloxacin; systemic

1.6

323.0

11094

63730

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.6

323.0

2279

3548

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

323.0

3455

12862

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.9

323.0

3888

11902

Z2446

NOMESCO Finland

Social worker

2.7

323.0

2513

8043

A28

ICPC

Limited function/disability NOS

3.1

323.0

3688

10673

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.9

323.0

7169

23421

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.7

323.0

1706

3928

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

323.0

8793

43044

J01FA06

ATC

roxithromycin; oral

1.9

323.0

14016

75101

H02AB07

ATC

prednisone; oral

2.1

323.0

4567

18779

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

9.5

323.0

1023

905

Z3231

NOMESCO Finland

Registered nurse

1.8

323.0

8743

44245

J96.1

ICD-10 Finland

Chronic respiratory failure

13.7

323.0

757

462

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.8

323.0

18169

64693

AA1AD

NOMESCO Finland

CT of head and brain

2.2

323.0

6943

29389

N03AX16

ATC

pregabalin; oral

1.9

323.0

7500

36942

48509

ICD-8 Finland

Bronchopneumonia, unspecified

+∞

323.0

1685

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

323.0

8743

45449

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.4

323.0

6462

14031

B01AA03

ATC

warfarin; systemic

2.5

323.0

4161

15004

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

323.0

5011

20681

SPAT1254

SPAT

Administration of medicine

2.1

323.0

4309

17872

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.2

323.0

2115

5674

JN4BD

NOMESCO Finland

Extensive body CT

2.9

323.0

3670

11254

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

240.7

323.0

517

Z51.5

ICD-10 Finland

Palliative care

3.9

323.0

1570

3419

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

323.0

5521

25499

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.2

323.0

1149

1857

R02

ICPC

Shortness of breath/dyspnoea

2.5

323.0

3945

13770

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.7

323.0

2559

8109

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

25.3

323.0

907

302

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

39.8

323.0

506

106

C07AB07

ATC

bisoprolol; oral

1.8

323.0

12750

68577

R03DA04

ATC

theophylline; systemic, rectal

4.2

323.0

1467

2948

R03AC02

ATC

salbutamol; inhalant

2.0

323.0

19012

108120

R03BA05

ATC

fluticasone; inhalant

1.9

323.0

6164

29273

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.0

323.0

2397

5245

TGC00

NOMESCO Finland

Bronchial lavation

9.1

323.0

1333

1249

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

65.2

323.0

829

107

J01AA02

ATC

doxycycline; systemic

1.7

323.0

25324

175875

N05AH04

ATC

quetiapine; oral

2.0

323.0

5928

26545

C03CA01

ATC

furosemide; systemic

3.6

323.0

8100

22485

ZX120

NOMESCO Finland

Intravenous

2.8

323.0

3434

10678

B01AB05

ATC

enoxaparin; parenteral

1.7

323.0

8673

46222

J01MA14

ATC

moxifloxacin; systemic

7.3

323.0

5668

7384

A41.9

ICD-10 Finland

Sepsis, unspecified

6.8

323.0

1403

1749

J01MA12

ATC

levofloxacin; systemic

4.2

323.0

8546

20430

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.5

323.0

7338

27132

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

5.0

323.0

3309

5919

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

+∞

323.0

2683

TPH07

NOMESCO Finland

Cathetrisation of artery

2.7

323.0

3258

10396

R81

ICPC

Pneumonia

12.5

323.0

2094

1459

ZXD05

NOMESCO Finland

Urgent procedure

1.9

323.0

10200

51878

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

323.0

4855

17029

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.0

323.0

3403

5066

R50.9

ICD-10 Finland

Fever, unspecified

3.5

323.0

6290

17017

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.3

323.0

4987

19165

N03AG01

ATC

valproic acid; systemic, rectal

2.8

323.0

2416

7361

H02AB06

ATC

prednisolone; systemic

2.3

323.0

16851

83451

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

7.3

323.0

1266

1462

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

6.6

323.0

1013

1302

A03

ICPC

Fever

2.0

323.0

5935

27146

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

5.4

323.0

3037

4946

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

319.5

6404

31368

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

319.2

3584

13945

M04AA01

ATC

allopurinol; systemic

2.5

318.8

2860

9939

WX872

NOMESCO Finland

Intensive care

3.5

316.3

1638

3968

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

315.7

15305

95912

N05BA04

ATC

oxazepam; oral

1.7

315.4

7701

40168

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

313.5

1941

5371

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.1

313.1

4054

16803

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

307.6

8268

44326

N05BA06

ATC

lorazepam; systemic, sublingual

3.3

301.2

1709

4437

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.1

299.9

1294

2677

J86.9

ICD-10 Finland

Pyothorax without fistula

25.2

297.6

449

148

TK800

NOMESCO Finland

Hemodialysis

5.9

297.4

909

1295

R03BA02

ATC

budesonide; inhalant

1.8

297.0

5734

27646

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

296.7

10943

63811

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

295.2

6860

35128

J12.8

ICD-10 Finland

Other viral pneumonia

170.4

291.5

329

C03DA01

ATC

spironolactone; oral

2.5

291.2

2632

9163

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

287.6

6339

31888

TKC20

NOMESCO Finland

Catheterisation of bladder

3.0

284.1

1849

5285

J96.0

ICD-10 Finland

Acute respiratory failure

15.3

282.8

504

275

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.7

282.6

1060

1910

JN4AD

NOMESCO Finland

Body CT examination

2.6

282.4

2234

7213

R03DC03

ATC

montelukast; oral

1.8

281.5

5401

25933

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.8

280.3

1022

1787

N05AH03

ATC

olanzapine; systemic

2.5

278.3

2369

7973

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

277.5

3751

15774

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

275.7

4773

22086

S97

ICPC

Chronic ulcer skin

3.4

274.8

1499

3774

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

274.2

4011

17411

N06AX11

ATC

mirtazapine; oral

1.6

274.1

9836

56684

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

30.3

274.0

394

108

L04AA06

ATC

mycophenolic acid; systemic

5.6

272.8

866

1292

127

Kela drug reimbursment

Transplant complication

6.3

272.8

795

1064

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.2

271.5

1604

4283

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

5.8

270.5

841

1223

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

268.7

14360

90806

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.9

266.5

1219

2655

R03AC12

ATC

salmeterol; inhalant

3.5

265.2

1394

3408

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

265.0

2887

11019

R05

ICPC

Cough

1.7

263.8

6948

36755

R96

ICPC

Asthma

2.3

263.4

2787

10490

WX882

NOMESCO Finland

High dependency care

4.3

263.3

1064

2066

XG410

NOMESCO Finland

Flow-volume spirometry

3.4

262.2

1430

3597

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

10.1

261.6

562

463

N05AH02

ATC

clozapine; systemic

4.4

260.2

1026

1944

C08CA01

ATC

amlodipine; oral

1.6

259.3

8526

47896

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

258.7

3299

13509

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

12.5

258.4

500

332

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.5

258.0

2193

7367

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

5.0

257.0

896

1491

A10AE04

ATC

insulin glargine; parenteral

2.3

255.5

2751

10433

SPAT1263

SPAT

Sampling

1.5

255.1

12987

80934

R53

ICD-10 Finland

Malaise and fatigue

1.8

254.9

5676

28508

N05AX08

ATC

risperidone; systemic

2.5

254.9

2270

7820

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.9

254.1

779

1113

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.7

254.0

1952

6185

H02AB04

ATC

methylprednisolone; systemic

1.9

253.8

4468

20742

SPAT1262

SPAT

Handing over of treatment supplies

1.8

253.6

4968

23934

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

253.2

6573

34566

ZXE00

NOMESCO Finland

One hour or less

1.5

253.0

12135

74583

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.5

252.7

2228

7634

J20

ICD-10 Finland

Acute bronchitis

2.1

247.1

3046

12281

N06AB04

ATC

citalopram; systemic

1.7

245.2

6657

35413

WW500

NOMESCO Finland

Blood transfusion

3.4

244.6

1291

3164

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

243.8

3697

16224

R95

ICPC

Chron obstructive pulmonary disease

5.5

243.6

782

1182

R60.0

ICD-10 Finland

Localized oedema

2.2

242.5

2888

11461

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.4

241.9

2315

8275

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

7.3

241.6

629

717

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.3

241.4

1369

3542

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

239.3

3679

16220

130

Kela drug reimbursment

Malignant tumour

2.5

239.0

2103

7188

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

238.6

7322

40235

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.2

238.1

1370

3583

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

236.9

1470

4057

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

235.3

1956

6479

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.2

234.9

991

2003

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

14.6

234.9

426

243

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

234.1

4358

20582

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.1

233.8

997

2036

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.1

233.0

1007

2082

WX730

NOMESCO Finland

Conventional respirator

6.5

229.8

651

838

J45

ICD-10 Finland

Asthma

2.1

228.5

3113

13071

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.3

227.5

1280

3291

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

226.4

10924

66776

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

225.9

2239

8137

T90

ICPC

Diabetes non-insulin dependent

1.7

225.3

5725

29788

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.2

224.3

2625

10321

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

224.1

4229

20040

Z2221

NOMESCO Finland

Medical doctor

1.6

223.2

8397

48444

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

6.6

223.1

627

798

48601

ICD-8 Finland

More specifically, unspecified pneumonia and the pleural irritation caused by it

+∞

222.1

230

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.4

222.0

1209

3033

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.2

221.3

755

1225

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.7

220.8

1051

2365

J01DA01

ATC

[U] cefalexin; systemic

1.4

220.8

19633

135544

C09AA05

ATC

ramipril; oral

1.7

220.5

5462

28186

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.6

219.6

1103

2596

N05AF03

ATC

chlorprothixene; systemic

3.4

218.5

1150

2809

A07AA02

ATC

nystatin; oral

2.6

217.8

1820

6039

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

217.4

2737

11106

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.1

216.9

751

1239

SPAT1229

SPAT

Assessment of need for aid

2.5

216.7

1956

6769

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

215.2

10253

62324

C01AA05

ATC

digoxin; systemic

3.4

214.3

1146

2834

WZC30

NOMESCO Finland

Teaching

1.9

213.9

3891

18187

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

213.3

6626

36368

A02BC01

ATC

omeprazole; systemic

1.6

213.0

7502

42502

H02AB02

ATC

dexamethasone; systemic

2.0

212.7

3012

12825

R11

ICD-10 Finland

Nausea and vomiting

2.2

212.5

2396

9252

WX002

NOMESCO Finland

Sedation and analgesia

1.7

211.5

5450

28413

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

3.4

209.1

1133

2830

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

208.7

14155

92333

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.9

207.5

627

879

A04AA01

ATC

ondansetron; systemic, rectal

2.3

207.0

2077

7583

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.2

206.0

1174

3045

A10BA02

ATC

metformin; oral

1.6

205.5

6594

36442

N05AD01

ATC

haloperidol; systemic

3.8

205.1

946

2071

J45.8

ICD-10 Finland

Mixed asthma

3.5

204.7

1064

2572

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.3

204.0

2065

7569

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.6

203.4

1002

2320

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.9

203.2

1389

4082

R05

ICD-10 Finland

Cough

1.7

202.3

5598

29732

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

60.1

201.8

254

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

201.6

2002

7266

J15.8

ICD-10 Finland

Other bacterial pneumonia

37.9

201.4

275

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

198.8

4259

20970

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

198.6

3130

13871

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

5.7

197.5

614

892

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.7

197.3

1483

4622

205

Kela drug reimbursment

Chronic hypertension

1.6

196.1

5626

30141

R03BA01

ATC

beclometasone; inhalant

1.8

195.8

4094

19994

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

195.3

4886

25196

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.3

194.7

2045

7628

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

193.7

12924

83633

C01DA14

ATC

isosorbide mononitrate; oral

2.2

193.3

2111

8019

S18

ICPC

Laceration/cut

1.4

192.5

11608

73635

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.9

191.9

686

1172

B01AC04

ATC

clopidogrel; oral

1.9

190.7

2961

13037

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.5

189.0

1654

5617

N03AX12

ATC

gabapentin; oral

1.7

188.7

4416

22306

R03AK08

ATC

formoterol and beclometasone; inhalant

2.9

188.6

1287

3776

R04.2

ICD-10 Finland

Haemoptysis

3.7

187.8

891

1998

R03AC03

ATC

terbutaline; inhalant

1.7

187.5

4302

21598

WX722

NOMESCO Finland

PEEP

2.7

187.4

1394

4316

207

Kela drug reimbursment

Chronic arrhythmias

2.0

187.1

2617

11062

XW000

NOMESCO Finland

Bone marrow biopsy

3.1

185.9

1145

3134

N18.8

ICD-10 Finland

Other chronic renal failure

4.5

185.0

710

1307

B03XA02

ATC

darbepoetin alfa; parenteral

5.5

184.6

594

900

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.6

183.6

895

2053

M05BA04

ATC

alendronic acid; oral

2.3

183.5

1887

6961

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

183.0

6987

40119

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.8

183.0

1325

4033

AN1

Coronary angiography

2.1

182.3

2233

8926

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

181.7

5611

30576

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.5

181.4

921

2184

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.4

181.2

516

669

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

4.6

181.1

685

1242

N04AA02

ATC

biperiden; systemic

4.0

180.7

794

1664

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

5.0

180.4

636

1070

N07BB01

ATC

disulfiram; oral

2.4

179.4

1642

5709

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.1

179.2

1074

2885

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

179.1

11438

73081

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.7

179.1

866

1973

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

178.3

6272

35287

XG466

NOMESCO Finland

Sleep oxymetry

3.1

178.2

1070

2879

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

41.2

178.1

239

I50.1

ICD-10 Finland

Left ventricular failure

3.7

177.8

849

1914

ZXA00

NOMESCO Finland

Right side

1.5

176.6

7050

40845

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

176.5

6161

34585

N03AE01

ATC

clonazepam; systemic

2.3

175.4

1817

6724

J01FA09

ATC

clarithromycin; systemic

1.4

174.9

10004

62500

R03AC13

ATC

formoterol; inhalant

2.5

174.6

1461

4840

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

174.0

3172

14768

UJF32

NOMESCO Finland

Coloscopy

1.5

173.5

6623

37954

M79.6

ICD-10 Finland

Pain in limb

1.4

172.9

10304

64856

WW200

NOMESCO Finland

Immunization

3.1

172.3

1021

2719

L04AX01

ATC

azathioprine; systemic

2.5

172.1

1529

5231

R03BB01

ATC

ipratropium bromide; inhalant

3.6

171.1

834

1912

201

Kela drug reimbursment

Chronic cardiac insufficiency

3.4

170.6

907

2230

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.5

169.9

876

2102

A11CC03

ATC

alfacalcidol; systemic

4.1

169.5

726

1486

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

168.9

1452

4880

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

1526.1

168.7

177

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

168.0

10888

69531

J18

ICD-10 Finland

Pneumonia, organism unspecified

9.6

167.4

368

317

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.9

166.8

595

1014

M05BX04

ATC

denosumab; parenteral

2.7

166.1

1219

3739

SPAT1216

SPAT

Assessment of functional ability

1.8

164.8

3337

16067

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.3

164.8

1727

6420

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

164.6

3284

15737

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.4

164.5

1589

5674

G47.3

ICD-10 Finland

Sleep apnoea

1.5

163.7

6155

35083

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

163.7

2528

11078

ZXA05

NOMESCO Finland

Left side

1.5

161.5

6477

37448

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

161.2

1791

6842

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

160.9

8672

53355

C10AA01

ATC

simvastatin; oral

1.4

159.8

9286

57963

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.9

159.6

1065

3076

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

159.6

1746

6623

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.3

159.2

1635

6017

N06AA09

ATC

amitriptyline; systemic

1.9

158.7

2776

12720

M10.9

ICD-10 Finland

Gout, unspecified

2.5

157.8

1328

4409

K08.3

ICD-10 Finland

Retained dental root

2.1

157.5

1946

7791

N03AX09

ATC

lamotrigine; oral

2.2

157.1

1681

6307

WX110

NOMESCO Finland

Local anesthesy

1.4

157.1

22366

162457

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

156.4

162

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.4

155.5

1434

5000

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

5.5

153.8

496

754

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

6.9

153.4

415

501

N06AX16

ATC

venlafaxine; oral

1.6

152.8

4438

23689

49300

ICD-8 Finland

Asthma, bronchiale

3.5

152.4

772

1826

B01AF02

ATC

apixaban; oral

2.1

151.5

1840

7310

L03AA02

ATC

filgrastim; parenteral

3.3

151.0

850

2181

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.4

150.3

799

1963

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

7.8

150.2

372

393

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.5

150.2

1309

4425

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.8

149.9

410

503

R06.2

ICD-10 Finland

Wheezing

2.4

149.8

1357

4686

Z94.0

ICD-10 Finland

Kidney transplant status

5.3

149.1

491

765

R33

ICD-10 Finland

Retention of urine

2.5

148.8

1268

4236

J01FA15

ATC

telithromycin; oral

1.8

148.7

3157

15398

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.8

148.5

691

1523

N19

ICD-10 Finland

Unspecified kidney failure

4.0

148.2

651

1364

I50

ICD-10 Finland

Heart failure

5.3

147.5

492

778

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

146.8

1284

4350

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.9

146.5

664

1430

W19

ICD-10 Finland

Unspecified fall

1.9

145.6

2518

11476

SPAT1234

SPAT

Support of social functional capacity

2.6

145.1

1143

3651

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

144.9

2754

12958

E86

ICD-10 Finland

Volume depletion

4.6

144.5

544

982

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

3.0

144.1

897

2471

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.1

143.9

612

1245

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.5

143.8

734

1747

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.3

143.3

577

1114

A04

ICPC

Weakness/tiredness general

1.7

143.3

3277

16340

N05BA02

ATC

chlordiazepoxide; systemic

3.2

142.2

809

2090

ZX108

NOMESCO Finland

Inhalation

8.0

141.7

345

355

L04AD01

ATC

ciclosporin; systemic

3.5

140.2

723

1735

N05AA01

ATC

chlorpromazine; systemic, rectal

4.2

140.0

578

1143

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

138.1

2171

9554

ZXA10

NOMESCO Finland

Bilateral

1.6

137.8

4654

25741

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

137.5

1546

5929

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.5

137.5

528

973

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.2

136.7

399

535

SPAT1301

SPAT

No procedures

1.4

136.4

8438

52957

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

136.2

1976

8433

L17

ICPC

Foot/toe symptom/complaint

1.5

136.1

6735

40503

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.6

135.9

426

626

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

134.9

2153

9526

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

134.4

3742

19697

A41.8

ICD-10 Finland

Other specified sepsis

5.3

134.3

443

692

Z71.8

ICD-10 Finland

Other specified counselling

1.4

133.9

7021

42686

V03AE01

ATC

polystyrene sulfonate; oral

6.6

133.9

374

473

H02AB09

ATC

hydrocortisone; systemic

3.1

133.6

798

2137

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.6

133.2

419

618

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

133.1

8843

56165

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

132.4

1516

5858

J94.8

ICD-10 Finland

Other specified pleural conditions

5.8

132.3

407

584

A12BA01

ATC

potassium chloride; oral

3.3

132.2

728

1837

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.1

132.2

1561

6115

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

132.1

1669

6731

A12AA04

ATC

calcium carbonate; oral

4.7

131.9

487

862

N03AF01

ATC

carbamazepine; oral, rectal

2.3

131.5

1381

5129

47099

ICD-8 Finland

Influenza, unqualified

+∞

131.2

136

N05AB03

ATC

perphenazine; systemic, rectal

2.5

131.1

1164

3973

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

131.1

2177

9768

N05AX12

ATC

aripiprazole; systemic

2.3

130.7

1372

5093

N18.0

ICD-10 Finland

End-stage renal disease

6.3

130.5

375

493

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.8

129.3

2571

12253

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

129.2

2608

12492

B01AB10

ATC

tinzaparin; parenteral

2.0

129.1

1804

7583

E87.6

ICD-10 Finland

Hypokalaemia

2.9

129.0

836

2366

R41.0

ICD-10 Finland

Disorientation, unspecified

3.7

128.6

606

1350

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

127.8

2843

14031

N30.0

ICD-10 Finland

Acute cystitis

1.6

127.6

3488

18253

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

126.5

3090

15671

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.2

126.1

519

1024

GBB00

NOMESCO Finland

Tracheostomy

6.1

125.6

372

509

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

125.5

4761

26998

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

4.2

125.1

518

1028

R06AE07

ATC

cetirizine; oral

1.3

124.6

13530

92734

J43.9

ICD-10 Finland

Emphysema, unspecified

6.4

124.3

355

463

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.5

124.0

349

446

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

11.9

123.3

243

169

EBA00

NOMESCO Finland

Extraction of tooth

1.4

123.2

9725

63410

C07AB02

ATC

metoprolol; systemic

1.6

123.0

4041

22146

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.9

122.4

833

2433

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

122.2

11340

75832

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

121.9

2428

11569

R4190

NOMESCO Finland

Nutritional therapy

2.4

121.2

1131

3960

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.6

121.1

379

556

E87.5

ICD-10 Finland

Hyperkalaemia

5.6

120.8

379

558

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

120.6

7355

45851

P72

ICPC

Schizophrenia

3.2

120.6

699

1832

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

120.4

1884

8261

N06AA12

ATC

doxepin; systemic

2.1

120.2

1413

5521

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

120.2

3078

15807

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.7

119.9

892

2755

N05AC02

ATC

thioridazine; oral

3.2

119.9

700

1844

N06AB03

ATC

fluoxetine; oral

1.6

119.8

3647

19605

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.9

119.6

786

2244

SPAT1104

SPAT

Monitoring of emergency patient

2.0

119.6

1704

7212

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.5

119.1

336

431

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

118.1

943

3032

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.6

117.3

445

810

C09AA02

ATC

enalapril; systemic

1.5

116.6

3985

22024

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

116.5

1279

4844

P01AB01

ATC

metronidazole; oral, rectal

1.3

116.5

11497

77441

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

116.3

7036

43753

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

116.2

2126

9848

F05.9

ICD-10 Finland

Delirium, unspecified

4.6

115.2

432

777

R05FB02

ATC

cough suppressants and expectorants

1.3

115.1

10055

66449

N03AX14

ATC

levetiracetam; systemic

2.8

114.8

783

2291

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

4.6

114.7

429

770

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

113.7

2088

9683

A10BB12

ATC

glimepiride; oral

2.3

113.2

1180

4363

R03AK11

ATC

formoterol and fluticasone; inhalant

2.8

113.1

791

2350

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.3

113.0

1112

3996

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

3.6

112.9

548

1252

N05AN01

ATC

lithium; oral

2.7

112.8

859

2688

N05AF05

ATC

zuclopenthixol; systemic

4.5

112.8

436

809

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

112.6

1348

5306

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.5

112.2

427

780

A02BC05

ATC

esomeprazole; systemic

1.3

112.0

11286

76130

UKC02

NOMESCO Finland

Cystoscopy

1.6

111.9

3008

15637

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

4.9

111.8

395

667

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

111.7

1684

7278

E66.8

ICD-10 Finland

Other obesity

2.0

110.7

1630

6980

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

110.7

1729

7570

G72.8

ICD-10 Finland

Other specified myopathies

4.8

110.6

398

686

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

110.5

1986

9139

137

Kela drug reimbursment

Uraemia requiring dialysis

5.9

110.5

335

473

P15

ICPC

Chronic alcohol abuse

2.5

110.4

931

3089

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

110.3

2346

11401

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

110.2

1267

4900

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.0

110.1

697

1942

N17.8

ICD-10 Finland

Other acute renal failure

6.2

109.8

318

423

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

109.6

2530

12599

SPAT1325

SPAT

Vaccination

1.4

109.5

8270

53313

WF004

NOMESCO Finland

Palliative radiotherapy

4.0

109.2

473

979

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

2.8

109.2

747

2189

A04AA02

ATC

granisetron; systemic, transdermal

2.0

109.0

1609

6899

E0000UV

ATC

1.3

108.9

11358

76914

R42

ICD-10 Finland

Dizziness and giddiness

1.5

108.9

4995

29408

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

108.6

1261

4897

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

108.5

1160

4340

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.3

108.2

432

828

A10AE05

ATC

insulin detemir; parenteral

2.0

108.2

1464

6066

A10BH01

ATC

sitagliptin; oral

1.8

107.9

2046

9583

SPAT1260

SPAT

Consultation of another employee

1.5

107.6

4652

27052

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

107.5

1501

6297

J15.7

ICD-10 Finland

Pneumonia due to Mycoplasma pneumoniae

23.7

107.5

164

K78

ICPC

Atrial fibrillation/flutter

2.2

107.4

1166

4392

N06AX21

ATC

duloxetine; oral

1.6

107.3

3089

16342

S06.0

ICD-10 Finland

Concussion

1.7

107.1

2763

14191

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.8

106.4

380

650

A29

ICPC

General symptom/complaint other

1.7

106.4

2636

13389

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

106.1

1800

8117

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.2

105.7

595

1524

RS221

NOMESCO Finland

3.5

105.5

533

1259

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

105.5

694

1983

A02BA02

ATC

ranitidine; systemic

1.5

105.4

4614

26890

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

105.0

1797

8128

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.3

104.9

577

1455

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

6.7

104.8

286

351

SPAT1252

SPAT

Overall medication plan or its review

2.0

104.4

1481

6251

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.1

104.4

637

1730

ZY010

NOMESCO Finland

Hospital outpatient

1.9

103.4

1560

6742

N06AB06

ATC

sertraline; oral

1.6

103.3

3250

17573

A08

ICPC

Swelling

2.4

103.1

953

3318

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.2

102.6

1145

4366

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

7.9

102.4

251

262

A01AB09

ATC

miconazole; local oral

1.7

102.0

2182

10612

L04AA01

ATC

[U] ciclosporin; systemic

3.5

101.8

510

1196

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

101.8

7370

47081

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

7.2

101.3

263

300

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

6.4

101.3

288

374

R55

ICD-10 Finland

Syncope and collapse

1.7

101.1

2243

11025

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

101.0

3118

16772

NHQ40

NOMESCO Finland

Amputation of toe

4.7

100.7

369

649

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.3

100.7

551

1385

S22.3

ICD-10 Finland

Fracture of rib

1.9

100.6

1549

6741

A07AA09

ATC

vancomycin; oral

4.7

100.5

372

661

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

99.8

3391

18666

A10BH05

ATC

linagliptin; oral

2.5

99.8

852

2846

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.3

99.5

1027

3778

G04CA02

ATC

tamsulosin; oral

1.6

99.5

3095

16680

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

3.0

99.4

625

1734

C02AC05

ATC

moxonidine; oral

2.3

98.4

983

3559

I25.2

ICD-10 Finland

Old myocardial infarction

2.4

98.2

890

3068

R13

ICD-10 Finland

Dysphagia

1.9

98.0

1480

6394

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.6

97.9

774

2474

F10.24

ICD-10 Finland

Alcohol depence active use

3.3

97.7

525

1301

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

97.7

2185

10764

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.4

97.6

886

3057

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

97.5

1068

4039

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.6

97.5

477

1098

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

97.3

1317

5454

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.0

97.2

624

1755

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

97.2

1818

8469

C10AA05

ATC

atorvastatin; oral

1.3

96.8

8439

55421

B03XA01

ATC

erythropoietin; parenteral

7.1

96.7

255

298

M54.5

ICD-10 Finland

Low back pain

1.3

96.4

9343

62319

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.3

96.3

385

740

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.6

95.9

783

2551

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.7

95.9

705

2161

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

95.8

2949

15840

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

95.6

2255

11280

ZZA00

NOMESCO Finland

Split skin graft

2.8

95.3

677

2031

A02BC03

ATC

lansoprazole; oral

1.3

95.2

7391

47659

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.0

94.9

406

832

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

94.5

4339

25482

R51.80

ICD-10 Finland

Headache

1.5

94.2

4165

24270

TFP20

NOMESCO Finland

Cardiodefibrillation

2.0

93.9

1383

5916

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

9.4

93.9

208

183

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

4.5

93.7

359

661

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.4

93.6

830

2829

N06AX03

ATC

mianserin; oral

2.0

93.5

1255

5177

K92.1

ICD-10 Finland

Melaena

2.2

93.4

999

3734

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.9

93.2

625

1809

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.8

92.8

428

938

XF404

NOMESCO Finland

Ambulatory ECG

1.7

92.7

2094

10341

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.3

92.7

513

1301

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.6

92.5

289

424

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

91.1

2132

10636

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.3

91.0

878

3124

S72.0

ICD-10 Finland

Fracture of neck of femur

3.2

90.9

522

1359

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.5

90.6

344

628

N05BA12

ATC

alprazolam; oral

1.6

89.9

2774

14898

4829X

ICD-9 Finland

Other bacterial pneumonia, Bacterial pneumonia unspecified

+∞

89.7

K07

ICPC

Swollen ankles/oedema

2.4

89.6

830

2892

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

89.5

4166

24506

S01.0

ICD-10 Finland

Open wound of scalp

1.8

89.5

1704

7979

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.3

89.4

492

1242

A01

ICPC

Pain general/multiple sites

1.7

89.2

1872

9040

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

89.2

2123

10641

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.3

89.2

883

3183

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

3.3

89.1

481

1197

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

89.0

759

2533

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.8

88.9

317

542

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

88.9

1155

4703

TK810

NOMESCO Finland

Hemofiltration

6.8

88.8

241

294

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.0

88.7

563

1572

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.0

88.6

550

1513

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

88.6

9953

67584

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.7

88.4

638

1935

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.7

88.0

637

1933

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

87.7

940

3518

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

87.6

4612

27768

N05BE01

ATC

buspirone; oral

2.3

87.6

866

3119

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.8

87.4

315

545

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

14.1

87.3

159

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.6

87.1

674

2130

ZX112

NOMESCO Finland

Subcutaneous

2.9

87.0

577

1657

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

86.9

2522

13332

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

86.9

3275

18420

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

86.8

1756

8378

R03BA08

ATC

ciclesonide; inhalant

1.6

86.8

2214

11308

RS220

NOMESCO Finland

3.4

86.8

454

1103

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

86.7

1077

4305

V03AA01

ATC

3.1

86.5

520

1400

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.9

86.3

383

812

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.3

86.2

847

3042

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

85.9

1007

3924

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

85.6

2153

10955

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

85.4

1444

6494

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

85.0

1322

5771

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

84.9

2453

12949

N03AF02

ATC

oxcarbazepine; oral

2.2

84.8

889

3292

U04

ICPC

Incontinence urine

2.2

84.7

911

3413

XG460

NOMESCO Finland

Short time oxymetry

3.9

84.6

373

786

Z49.2

ICD-10 Finland

Other dialysis

5.8

84.5

259

372

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.6

84.4

661

2104

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

84.2

1249

5355

SPAT1167

SPAT

Insertion of urinary catheter

3.1

84.2

506

1362

X58

ICD-10 Finland

Exposure to other specified factors

1.4

84.1

3893

22849

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

83.8

7503

49275

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

11.6

83.7

166

118

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

83.6

1856

9112

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

83.6

3082

17245

K92.0

ICD-10 Finland

Haematemesis

2.9

83.4

553

1590

49099

ICD-8 Finland

Bronchitis, unspecified

3.8

83.4

387

853

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

4.5

83.2

319

589

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.3

83.0

328

624

B05DA

ATC

Isotonic solutions

5.6

83.0

261

387

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.7

82.8

611

1878

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

82.7

3205

18126

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.8

82.6

587

1764

R4120

NOMESCO Finland

Occupational therapy

1.8

82.5

1636

7755

D07AC01

ATC

betamethasone; topical

1.3

82.1

9043

61094

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

82.1

2387

12615

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.4

82.1

749

2591

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.0

81.7

514

1428

Z94.2

ICD-10 Finland

Lung transplant status

20.8

81.6

129

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

81.3

1890

9401

C08CA02

ATC

felodipine; oral

1.8

80.8

1631

7775

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

80.7

1919

9609

EBA30

NOMESCO Finland

Excision of root of tooth

1.9

80.6

1299

5745

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.6

80.5

2527

13611

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.3

80.4

781

2788

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

80.4

5400

33884

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.7

80.4

385

872

R29

ICPC

Respiratory symptom/complaint other

1.8

80.3

1637

7830

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.0

80.0

350

733

JAH00

NOMESCO Finland

Laparotomy

2.5

79.8

658

2155

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

79.7

2210

11536

R07.3

ICD-10 Finland

Other chest pain

1.6

79.6

2229

11666

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.7

79.6

293

519

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.3

79.3

800

2910

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

79.3

11075

77050

J01FA10

ATC

azithromycin; systemic

1.2

79.3

18544

136952

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.1

79.3

995

3993

L01CA04

ATC

vinorelbine; systemic

5.6

79.3

250

372

SPAT1324

SPAT

Screening procedure

0.7

79.3

2917

33332

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

12.1

79.2

154

105

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.2

79.1

325

642

TGA30

NOMESCO Finland

Thoracocentesis

8.1

78.8

190

194

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.3

78.6

314

604

J01CF05

ATC

flucloxacillin; systemic

2.1

78.6

985

3950

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

25.4

78.4

117

SPAT1097

SPAT

Recording of ECG

1.5

78.3

3221

18438

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.1

78.2

932

3656

V03AE02

ATC

sevelamer; oral

7.0

78.0

207

245

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

77.9

965

3851

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.3

77.6

415

1026

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

77.6

1601

7683

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.1

77.4

261

420

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.0

77.4

337

703

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

14.5

77.3

139

OAB43

SPAT

0.7

77.2

3118

35088

C90.0

ICD-10 Finland

Multiple myeloma

5.2

77.1

258

412

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.5

76.8

642

2117

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

76.8

996

4050

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

3.4

76.5

394

947

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.3

76.1

775

2830

N07BA03

ATC

varenicline; oral

1.8

76.0

1542

7361

J96.9

ICD-10 Finland

Respiratory failure, unspecified

7.9

76.0

185

192

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.0

75.9

323

660

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.1

75.8

452

1210

P01BA02

ATC

hydroxychloroquine; oral

1.6

75.8

2140

11221

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.4

75.7

213

274

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.7

75.7

568

1764

Z72.0

ICD-10 Finland

Tobacco use

2.3

75.6

737

2635

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.1

75.6

920

3643

N05AB01

ATC

dixyrazine; systemic

3.5

75.4

381

902

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

75.0

673

2307

E000001

ATC

1.3

74.9

5549

35321

C08CA13

ATC

lercanidipine; oral

1.5

74.8

2620

14473

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

6.7

74.6

204

252

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.7

74.3

549

1690

I20.09

ICD-10 Finland

Unstable angina

2.1

74.1

899

3554

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

74.0

988

4065

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

7.4

73.9

189

212

XKD00

NOMESCO Finland

Uroflowmetry

1.6

73.7

2395

12996

S76

ICPC

Skin infection other

1.9

73.6

1188

5254

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

5.0

73.3

252

415

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.7

73.2

527

1596

B34.9

ICD-10 Finland

Viral infection, unspecified

2.2

73.2

813

3092

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.1

73.2

432

1149

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

73.1

2545

14032

SPAT1211

SPAT

Application of soft bandage

1.6

72.9

2174

11550

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

3.6

72.9

349

791

N06AB10

ATC

escitalopram; oral

1.3

72.8

5798

37301

C01BD01

ATC

amiodarone; systemic

2.7

72.8

543

1681

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

3.0

72.7

455

1259

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.8

72.6

1254

5678

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.3

72.5

238

372

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.6

72.3

349

796

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

72.3

2728

15315

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

72.2

2338

12672

J01DA06

ATC

[U] cefuroxime; systemic

1.4

72.2

3905

23560

J80

ICD-10 Finland

Adult respiratory distress syndrome

15.8

72.0

125

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.3

71.7

289

561

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

71.6

1670

8308

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.3

71.6

385

957

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

71.4

1397

6589

J02AC03

ATC

voriconazole; systemic

17.5

71.1

119

N02AA01

ATC

morphine; systemic, rectal

5.5

71.0

224

334

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.7

70.8

334

748

M48.0

ICD-10 Finland

Spinal stenosis

1.5

70.8

2305

12511

WX402

NOMESCO Finland

General anaesthesia

1.4

70.7

4555

28318

R31

ICD-10 Finland

Unspecified haematuria

1.7

70.7

1634

8106

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.5

70.7

577

1879

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.2

70.6

399

1028

G41.9

ICD-10 Finland

Status epilepticus, unspecified

6.6

70.3

194

243

Z00.0

ICD-10 Finland

General medical examination

1.4

70.3

4649

29022

J01EA01

ATC

trimethoprim; systemic

1.3

70.2

6068

39482

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

70.2

1651

8234

K77

ICPC

Heart failure

4.4

70.2

271

505

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.6

70.1

552

1763

L04AX04

ATC

lenalidomide; oral

8.5

69.9

163

158

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.1

69.8

418

1123

196

Kela drug reimbursment

Paricalcitol and cinacalcet

6.9

69.8

187

225

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.5

69.3

348

820

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.2

69.2

751

2827

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.6

69.1

554

1787

L03AA13

ATC

pegfilgrastim; parenteral

2.0

68.9

961

4021

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

68.9

1204

5472

R52.9

ICD-10 Finland

Pain, unspecified

1.6

68.4

2075

11066

Angiography of the heart and coronary arteries

2.2

68.3

741

2787

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.6

68.3

553

1794

P29

ICPC

Psychological sympt/compl other

1.7

68.3

1640

8224

TJD20

NOMESCO Finland

Change of gastrostomy tube

8.3

68.3

161

159

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

68.1

6065

39609

120

Kela drug reimbursment

Hypogammaglobulinaemia

13.7

68.1

125

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

3.2

68.1

394

1034

H3603, E103

ICD-10 Finland

3.2

68.0

382

981

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

68.0

2048

10902

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.2

67.8

278

549

ZXD35

NOMESCO Finland

Usual procedure

2.1

67.8

842

3365

K65.0

ICD-10 Finland

Acute peritonitis

4.0

67.7

290

597

ZY000

NOMESCO Finland

Hospital inpatient

2.9

67.7

436

1230

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

67.6

2481

13832

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

67.5

1927

10124

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

67.5

2457

13676

WYA20

NOMESCO Finland

Home visit

4.2

67.2

276

546

348

Kela drug reimbursment

Roflumilast

18.5

67.1

110

F61.0

ICD-10 Finland

Mixed personality disorders

2.5

67.1

574

1920

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.9

67.0

984

4202

UJD02

NOMESCO Finland

Gastroscopy

1.9

66.9

1054

4618

153

Kela drug reimbursment

Lenalidomid

7.6

66.9

167

181

SPAT1251

SPAT

Organisation of medication

2.2

66.6

727

2745

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

66.6

2345

12956

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.0

66.5

963

4091

R28

ICPC

Limited function/disability (R)

3.7

66.5

312

696

T89

ICPC

Diabetes insulin dependent

1.9

66.3

1104

4932

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

66.3

2852

16444

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

66.3

1218

5631

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.7

66.2

481

1466

B01AB04

ATC

dalteparin; parenteral

1.9

66.2

1041

4561

A99

ICPC

Disease/condition unspecnature/site

1.6

66.0

1797

9320

K59.0

ICD-10 Finland

Constipation

1.9

66.0

1124

5064

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

66.0

3778

40396

C09CA01

ATC

losartan; oral

1.3

66.0

5245

33673

H25.8

ICD-10 Finland

Other senile cataract

1.7

65.9

1463

7171

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.9

65.8

427

1212

K02.1

ICD-10 Finland

Caries of dentine

1.2

65.8

17831

132490

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

65.6

1586

7968

5CM18

NOMESCO Finland

9.4

65.5

144

126

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

2.5

65.4

544

1791

P99

ICPC

Psychological disorders other

2.1

65.4

810

3232

SPAT1310

SPAT

Counselling related to known health issue

1.3

65.3

8525

58485

S29

ICPC

Skin symptom/complaint other

1.4

65.3

3995

24593

C08DB01

ATC

diltiazem; oral

2.2

65.1

719

2729

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

3.6

64.9

313

714

B05DB

ATC

Hypertonic solutions

5.4

64.9

209

320

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.1

64.8

220

358

GDG10

NOMESCO Finland

Bilateral transplantation of lung

23.7

64.6

R04.0

ICD-10 Finland

Epistaxis

1.7

64.3

1320

6319

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

64.3

754

2938

C03AA03

ATC

hydrochlorothiazide; oral

1.6

64.2

1775

9243

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

63.8

1423

6983

48099

ICD-8 Finland

Viral pneumonia

+∞

63.7

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

63.7

585

2032

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

4.5

63.7

240

437

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.4

63.5

572

1967

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

63.4

1451

7175

N05AD03

ATC

melperone; systemic

3.7

63.2

296

659

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.7

63.0

292

645

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.8

63.0

1258

5972

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

1.6

62.6

1572

7977

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.0

62.6

811

3295

S10

ICPC

Boil/carbuncle

1.7

62.5

1330

6437

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

5.4

62.3

200

305

RD210

NOMESCO Finland

2.4

62.3

546

1850

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

62.2

1461

7279

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

1.9

62.1

1001

4423

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.3

61.8

638

2348

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.3

61.8

175

228

29599

ICD-8 Finland

Schizophrenia, Unspecified type

5.4

61.8

199

305

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.9

61.7

415

1204

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

61.5

7398

50180

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

61.4

418

1223

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

5.9

61.4

184

258

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.3

61.4

331

826

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

61.3

1786

9424

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.8

61.3

427

1269

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.1

61.2

355

934

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.3

61.1

587

2085

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

7.9

61.1

149

156

WX704

NOMESCO Finland

Intubation

1.6

61.0

1734

9093

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.9

60.9

404

1165

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

7.7

60.5

150

161

I95.1

ICD-10 Finland

Orthostatic hypotension

2.7

60.5

452

1400

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.1

60.4

175

235

X57

ICD-10 Finland

Unspecified privation

2.4

60.3

571

2013

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.7

60.0

280

622

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

1.9

59.9

909

3929

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

59.9

3485

21251

F20.5

ICD-10 Finland

Residual schizophrenia

4.9

59.8

208

348

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.1

59.8

352

935

3AC01

NOMESCO Finland

3.5

59.7

300

709

-50

ICPC

Medication/prescr/renewal

1.9

59.6

923

4018

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

59.5

904

3908

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.9

59.4

971

4312

R74

ICPC

Upper respiratory infection acute

1.2

59.4

8536

59095

R03DX07

ATC

roflumilast; oral

18.6

59.3

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.2

59.3

343

900

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.9

59.3

207

348

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

4.3

59.2

236

455

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

59.1

21706

165298

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.0

59.1

362

990

RS222

NOMESCO Finland

3.2

59.0

333

858

I95.9

ICD-10 Finland

Hypotension, unspecified

3.7

59.0

278

623

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.1

59.0

684

2652

XG405

NOMESCO Finland

Education on PEF monitoring

2.8

58.8

409

1215

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

58.7

2577

14904

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

12.2

58.7

113

J01DC02

ATC

cefuroxime; systemic

1.6

58.6

1545

7944

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

58.5

3874

24127

R78

ICPC

Acute bronchitis/bronchiolitis

2.4

58.5

550

1932

N05CD02

ATC

nitrazepam; oral

3.1

58.4

352

951

ZX100

NOMESCO Finland

Oral

3.2

58.3

337

884

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.5

58.2

483

1589

XF402

NOMESCO Finland

ECG with work load test

1.5

58.2

2315

13118

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

5.8

58.2

176

250

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.6

58.1

464

1496

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

58.1

1418

7138

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.9

58.0

378

1077

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

57.9

2446

14037

R01AD08

ATC

fluticasone; nasal

1.2

57.7

8046

55472

Z29.0

ICD-10 Finland

Isolation

7.7

57.6

143

154

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

57.5

3170

19134

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

3.2

57.3

321

824

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

57.3

1716

9114

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

4.4

57.3

220

409

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

57.2

1087

5078

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.4

57.1

292

700

XQ800

NOMESCO Finland

Prick test

1.5

57.0

2102

11717

K85

ICD-10 Finland

Acute pancreatitis

2.8

56.9

400

1195

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

6.3

56.9

161

210

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

56.8

743

3033

K90

ICPC

Stroke/cerebrovascular accident

2.6

56.8

431

1350

A10AA02

ATC

2.0

56.8

792

3315

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

56.6

5621

37140

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.3

56.5

304

758

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.0

56.5

357

997

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2.9

56.4

363

1026

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.2

56.4

232

461

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.6

56.3

447

1435

A10BB01

ATC

glibenclamide; oral

2.8

56.2

378

1098

D07AB08

ATC

desonide; topical

1.4

56.2

2573

15002

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

56.1

1678

8906

WX212

NOMESCO Finland

Femoral plexus blockade

2.8

56.1

382

1118

J98.1

ICD-10 Finland

Pulmonary collapse

6.2

56.1

161

214

R03DC01

ATC

zafirlukast; oral

2.7

55.9

402

1219

SPAT1059

SPAT

Spirometry at the office

1.7

55.8

1158

5558

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

2.4

55.6

506

1750

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.6

55.6

440

1411

WW300

NOMESCO Finland

Transfer of autologic stem cells

5.8

55.5

168

239

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

55.4

1716

9188

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.1

55.4

327

870

V03AE03

ATC

lanthanum carbonate; oral

7.1

55.3

144

167

SPAT1172

SPAT

Guidance concerning hydration

3.0

55.2

336

915

F20

ICD-10 Finland

Schizophrenia

3.8

55.2

253

554

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.5

55.2

465

1544

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

3.9

55.2

245

522

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.2

55.1

573

2116

N06AB05

ATC

paroxetine; oral

1.6

55.1

1683

8982

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

55.1

692

2777

F20.10

ICD-10 Finland

Raise schizophrenia continuously

5.0

55.0

187

306

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

54.7

1410

7202

R03AC18

ATC

indacaterol; inhalant

5.2

54.7

181

287

C08CA05

ATC

nifedipine; systemic

1.7

54.6

1137

5465

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.1

54.6

664

2629

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

54.6

10879

77842

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.3

54.5

178

278

J10.8

ICD-10 Finland

Influenza with other manifestations, seasonal influenza virus identified

42.3

54.5

SPAT1053

SPAT

Memory test

1.5

54.4

1849

10119

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

54.3

503

1756

P16

ICPC

Acute alcohol abuse

2.4

54.3

473

1599

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

54.1

952

4335

C07AG02

ATC

carvedilol; oral

1.8

54.0

1014

4717

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

54.0

1117

5357

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

53.9

2263

12961

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.9

53.8

357

1030

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

2.9

53.8

355

1020

L03

ICPC

Low back symptom/complaint

1.3

53.8

6246

42073

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.8

53.7

247

543

WVA20

NOMESCO Finland

Medicine administration

2.3

53.6

524

1880

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

2.7

53.6

395

1215

A06AH03

ATC

naloxegol; oral

3.5

53.6

269

636

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.2

53.5

588

2228

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.8

53.4

371

1101

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

53.4

910

4098

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.9

53.2

344

976

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.4

53.2

492

1715

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.2

53.1

602

2313

48298

ICD-8 Finland

Other bacterial pneumonia, Other

+∞

53.1

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.1

53.0

622

2425

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.3

53.0

540

1974

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.9

53.0

141

169

K56.7

ICD-10 Finland

Ileus, unspecified

3.0

52.6

324

889

NF3AA

NOMESCO Finland

Femur X-ray examination

2.7

52.6

393

1220

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

52.4

1162

5689

XA800

NOMESCO Finland

Neuropsychological investigation

1.7

52.3

1073

5133

SPAT1240

SPAT

Therapeutic discussion

1.4

52.3

3019

18354

P18

ICPC

Medication abuse

4.1

52.2

218

440

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

52.2

1291

6523

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.4

52.2

203

383

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

52.1

720

3004

E000003

ATC

1.7

52.1

1137

5542

M10.0

ICD-10 Finland

Idiopathic gout

2.3

52.1

523

1899

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.4

52.0

274

673

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.1

52.0

636

2527

Z72.2

ICD-10 Finland

Drug use

4.1

52.0

216

434

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.6

52.0

249

567

GD1LA

NOMESCO Finland

3.2

51.9

288

735

R52.0

ICD-10 Finland

Acute pain

1.9

51.9

776

3338

R10.0

ICD-10 Finland

Acute abdomen

1.9

51.8

759

3239

N02AC04

ATC

dextropropoxyphene; oral

2.1

51.6

624

2467

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

26.1

51.6

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.8

51.6

966

4491

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

4.6

51.4

191

344

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

451.1

51.4

GDC00

NOMESCO Finland

Lobectomy of lung

6.3

51.3

145

189

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

51.3

1126

5498

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

6.2

51.2

147

196

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

3.7

51.1

238

529

R40.2

ICD-10 Finland

Coma, unspecified

4.1

51.1

215

437

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.4

51.0

479

1685

N05AL01

ATC

sulpiride; systemic

2.6

51.0

398

1268

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.7

50.9

239

535

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.7

50.8

185

326

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

50.8

11485

83040

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.3

50.6

500

1802

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

5.6

50.6

156

228

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.8

50.5

232

510

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

3.5

50.4

251

590

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

6.2

50.4

145

194

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.7

50.3

368

1128

N06AX12

ATC

bupropion; oral

1.5

50.3

1724

9448

R52.2

ICD-10 Finland

Other chronic pain

1.9

50.2

790

3461

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.5

50.2

434

1461

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

50.1

1114

5460

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

4.9

50.1

176

299

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

50.0

652

2658

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

49.9

3936

25137

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.8

49.9

346

1027

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.4

49.9

451

1556

TK820

NOMESCO Finland

Peritoneal dialysis

5.4

49.7

160

246

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

49.7

1782

9864

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.0

49.7

302

823

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

5.2

49.7

164

260

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.0

49.6

170

281

A01AB04

ATC

amphotericin B; local oral

1.8

49.6

961

4516

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.0

49.6

668

2759

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

11.7

49.6

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.2

49.5

544

2063

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

4.8

49.5

174

296

H05BX01

ATC

cinacalcet; oral

5.2

49.4

163

258

R03BB07

ATC

umeclidinium bromide; inhalant

4.2

49.3

202

401

WX726

NOMESCO Finland

High-flow oxygen therapy

70.5

49.3

SPAT1125

SPAT

Stoma care and guidance

3.5

49.2

248

589

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

3.9

49.2

218

465

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.3

49.2

496

1807

SPAT1281

SPAT

Other administrative function

1.5

49.1

1885

10591

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.4

49.1

443

1528

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.1

49.0

286

758

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.7

49.0

348

1048

SPF30

NOMESCO Finland

Soling for prothesis

2.7

48.9

353

1074

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

48.9

820

3674

H26.3

ICD-10 Finland

Drug-induced cataract

4.2

48.9

197

385

WNF00

NOMESCO Finland

Infection source and contact determination

6.4

48.9

137

177

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.2

48.8

270

689

P20

ICPC

Memory disturbance

1.6

48.7

1462

7762

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

6.4

48.7

136

175

N05CF02

ATC

zolpidem; oral

1.3

48.6

4603

30151

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.2

48.6

521

1953

F34.1

ICD-10 Finland

Dysthymia

1.8

48.6

939

4410

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

5.1

48.5

164

267

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

4.9

48.5

168

281

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.9

48.5

320

920

Z2445

NOMESCO Finland

Psychologist

1.7

48.5

1127

5592

D07AA02

ATC

hydrocortisone; topical

1.3

48.5

3524

22227

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

48.5

981

4675

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.3

48.3

257

637

N05CD08

ATC

midazolam; nasal, systemic

2.3

48.2

473

1698

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.2

48.2

538

2054

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

4.2

48.2

194

379

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

48.2

2840

17318

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.4

48.1

430

1474

F20.0

ICD-10 Finland

Paranoid schizophrenia

3.4

48.0

248

601

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.5

48.0

395

1296

A10AA01

ATC

1.9

47.9

726

3138

N06AA06

ATC

trimipramine; systemic

2.0

47.9

623

2538

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

6.2

47.9

137

182

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

47.8

1124

5598

PE1AT

NOMESCO Finland

Femoral artery PTA

4.1

47.8

199

401

H26.4

ICD-10 Finland

After-cataract

1.6

47.8

1264

6500

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.4

47.8

248

603

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.5

47.7

241

574

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

10.2

47.6

100

N18

ICPC

Paralysis/weakness

2.7

47.6

349

1072

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

47.6

16606

124585

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.3

47.6

483

1765

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

3.3

47.5

257

645

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

3.4

47.5

242

580

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

47.4

14380

106572

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

10.0

47.3

100

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.6

47.3

175

314

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

47.3

998

4817

Z72.1

ICD-10 Finland

Alcohol use

2.7

47.3

355

1107

Z94.1

ICD-10 Finland

Heart transplant status

8.0

47.3

114

118

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.1

47.2

561

2201

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

5.0

47.1

162

269

SPAT1312

SPAT

General health counselling

1.2

47.1

8673

61344

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.1

47.1

278

743

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.9

47.1

776

3457

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

47.0

1120

5601

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

3.9

46.9

208

444

SPD00

NOMESCO Finland

Fitting and preparation of total teeth prosthesis

3.2

46.9

265

686

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

3.1

46.7

274

729

S21

ICPC

Skin texture symptom/complaint

1.4

46.7

2749

16754

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

9.9

46.6

M05BA07

ATC

risedronic acid; oral

2.1

46.6

568

2252

L14

ICPC

Leg/thigh symptom/complaint

1.5

46.6

1566

8544

5AH02

NOMESCO Finland

76.8

46.5

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

6.2

46.4

132

174

J01FA01

ATC

erythromycin; systemic

1.3

46.4

3845

24712

S20.2

ICD-10 Finland

Contusion of thorax

1.7

46.4

1074

5327

WZA90

NOMESCO Finland

Other doctors statement

1.2

46.3

6297

43111

J42

ICD-10 Finland

Unspecified chronic bronchitis

3.1

46.2

272

726

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.0

46.1

280

761

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

46.1

906

4278

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

5.6

46.0

142

208

NGQ20

NOMESCO Finland

Amputation of lower leg

6.7

46.0

124

152

L04AA13

ATC

leflunomide; oral

2.0

46.0

640

2679

WX213

NOMESCO Finland

Lower leg blockade

3.8

46.0

205

440

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.7

46.0

327

987

Z03

ICPC

Housing/neighbourhood problem

4.0

45.9

194

397

M03BX01

ATC

baclofen; systemic

2.4

45.9

424

1479

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

45.9

822

3768

1240

FHL

Bronchoscopy

4.2

45.9

187

370

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.8

45.9

796

3611

L84

ICD-10 Finland

Corns and callosities

1.9

45.7

717

3139

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.1

45.7

529

2054

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.4

45.6

2081

12105

B02.9

ICD-10 Finland

Zoster without complication

1.7

45.6

1105

5551

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.7

45.6

2654

28446

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.5

45.5

230

548

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.3

45.5

242

600

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

45.5

1001

4892

A07EC01

ATC

sulfasalazine; oral, rectal

1.5

45.4

1971

11354

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

5.6

45.4

140

205

J15.0

ICD-10 Finland

Pneumonia due to Klebsiella pneumoniae

+∞

45.3

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.9

45.3

199

422

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

22.7

45.2

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.7

45.2

162

282

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.7

45.2

325

987

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.7

45.1

210

468

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.3

45.1

176

334

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.1

45.1

531

2075

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.3

45.0

241

601

C07AA05

ATC

propranolol; systemic

1.3

44.9

5162

34634

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.1

44.9

267

716

WX320

NOMESCO Finland

Spinalanesthesy

1.3

44.8

5133

34422

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

44.7

1727

9713

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.2

44.7

470

1748

J16.8

ICD-10 Finland

Pneumonia due to other specified infectious organisms

30.5

44.6

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.6

44.6

345

1095

29510

ICD-8 Finland

Schizophrenia, Hebephrenic type

6.9

44.6

118

141

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

44.6

4158

27156

R07.1

ICD-10 Finland

Chest pain on breathing

2.5

44.5

373

1236

AN3

Balloon angioplasty and metallic stent

2.5

44.5

373

1237

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

5.7

44.3

136

198

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.8

44.3

300

878

K99

ICPC

Cardiovascular disease other

2.3

44.3

433

1554

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

44.3

568

2301

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

4.1

44.2

181

360

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.2

44.1

251

654

WF002

NOMESCO Finland

Radical radiotherapy

1.8

44.1

817

3786

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

6.3

44.0

124

162

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.4

44.0

403

1401

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

6.6

43.9

120

150

6BA02

NOMESCO Finland

6.0

43.9

128

175

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

4.4

43.8

169

317

TAB00

NOMESCO Finland

Lumbar puncture

1.6

43.8

1094

5540

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.1

43.7

507

1971

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.9

43.6

717

3191

R01

ICPC

Pain respiratory system

2.4

43.5

395

1367

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

5.3

43.5

140

216

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

8.4

43.4

101

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

4.3

43.4

171

328

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.8

43.3

728

3266

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.5

43.2

357

1176

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

43.2

433

1573

N05AF01

ATC

flupentixol; systemic

2.3

43.2

406

1430

EBA10

NOMESCO Finland

Surgical removal of tooth

1.3

43.1

3333

21192

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.2

43.1

461

1727

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.4

43.1

219

525

T82

ICPC

Obesity

1.7

43.0

952

4659

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

43.0

2543

15498

NFQ20

NOMESCO Finland

Amputation of femur

8.4

43.0

100

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.5

42.9

352

1155

212

Kela drug reimbursment

Gout

2.9

42.9

274

774

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

5.4

42.8

137

210

J85.2

ICD-10 Finland

Abscess of lung without pneumonia

16.2

42.8

K93

ICPC

Pulmonary embolism

3.4

42.8

221

536

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

3.6

42.8

207

477

H03AA01

ATC

levothyroxine sodium; systemic

1.2

42.7

5751

39274

SPAT1058

SPAT

PEF monitoring instruction

1.4

42.6

1867

10771

U05

ICPC

Urination problems other

1.8

42.6

779

3595

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.3

42.6

430

1568

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

42.6

656

2852

R35

ICD-10 Finland

Polyuria

1.6

42.6

1123

5770

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

42.6

648

2808

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.5

42.5

345

1125

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.4

42.4

222

544

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.4

42.4

220

536

WX721

NOMESCO Finland

Oxygen concentrator therapy

14.2

42.4

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.8

42.3

750

3425

L05

ICPC

Flank/axilla symptom/complaint

1.6

42.3

1175

6118

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

4.6

42.3

156

280

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

42.3

1183

6173

J01GB01

ATC

tobramycin; inhalant, parenteral

45.2

42.3

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

7.8

42.2

103

109

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

42.2

614

2613

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

4.8

42.2

150

259

B01AF01

ATC

rivaroxaban; oral

1.4

42.2

2183

13001

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.1

42.2

173

345

E000006

ATC

1.5

42.1

1659

9366

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

42.1

1710

9719

B82

ICPC

Anaemia other/unspecified

2.3

42.0

418

1514

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.3

41.9

229

580

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.2

41.9

231

589

K56.0

ICD-10 Finland

Paralytic ileus

3.8

41.9

191

419

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

4.6

41.8

154

276

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.7

41.8

197

444

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

11.9

41.8

J05AB11

ATC

valaciclovir; oral

1.3

41.8

3114

19687

S01

ICPC

Pain/tenderness of skin

1.7

41.7

920

4498

D12

ICPC

Constipation

2.0

41.7

595

2516

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.2

41.6

235

608

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

41.6

1267

6753

R01AD09

ATC

mometasone; nasal

1.2

41.6

13130

97252

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.3

41.6

406

1456

R04

ICPC

Breathing problem other

1.8

41.6

771

3576

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

41.5

1316

7079

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

4.6

41.5

152

271

D11

ICPC

Diarrhoea

1.3

41.5

2853

17817

SPAT1153

SPAT

Removal of sutures

1.2

41.5

7555

53249

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

5.7

41.4

127

185

T78.4

ICD-10 Finland

Allergy, unspecified

1.6

41.4

1148

5974

SPAT1360

SPAT

Extensive global examination

1.5

41.4

1519

8448

Z50.1

ICD-10 Finland

Other physical therapy

1.6

41.4

1168

6109

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

41.3

870

4197

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.2

41.3

443

1662

R5110

SPAT

2.1

41.2

503

1998

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

3.7

41.2

193

433

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

6.1

41.1

118

158

L76

ICPC

Fracture: other

2.0

41.1

533

2171

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2.7

41.1

302

932

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

41.0

1211

6402

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

41.0

1066

5457

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.1

41.0

488

1919

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.7

40.9

147

257

N03AB02

ATC

phenytoin; systemic

3.1

40.8

239

637

R09.1

ICD-10 Finland

Pleurisy

2.3

40.7

398

1430

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

40.7

1523

8508

K28

ICPC

Limited function/disability (K)

2.6

40.6

317

1012

F60.2

ICD-10 Finland

Dissocial personality disorder

5.0

40.6

138

227

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.9

40.6

267

769

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

5.5

40.6

127

190

Z08

ICPC

Social welfare problem

2.6

40.6

319

1022

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

5.0

40.6

137

224

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.7

40.5

290

880

RF220

NOMESCO Finland

2.5

40.5

344

1150

U02

ICPC

Urinary frequency/urgency

1.3

40.4

2932

18455

5AB14

NOMESCO Finland

7.8

40.4

103

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.9

40.4

604

2601

C02EA02

ATC

2.1

40.4

503

2014

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.1

40.4

494

1964

SPAT1279

SPAT

Preparation of immediate hospitalisation

4.5

40.3

153

283

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.0

40.2

563

2365

RS230

NOMESCO Finland

4.0

40.2

171

353

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

3.6

40.2

196

455

A10BJ02

ATC

liraglutide; parenteral

2.0

40.2

539

2226

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.5

40.1

337

1121

K81.0

ICD-10 Finland

Acute cholecystitis

2.5

40.1

332

1094

OAA67

SPAT

0.7

40.0

1123

13550

H36.01

ICD-10 Finland

Diabetic maculopathy

2.7

39.9

283

854

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.7

39.9

858

4164

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

2.8

39.9

274

811

1XC02

NOMESCO Finland

3.6

39.8

194

450

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

7.4

39.8

100

111

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.3

39.8

215

541

J81

ICD-10 Finland

Pulmonary oedema

8.6

39.7

Z43.0

ICD-10 Finland

Attention to tracheostomy

16.0

39.7

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.9

39.7

657

2931

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.8

39.7

177

381

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

39.7

804

3833

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.1

39.6

493

1975

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

39.6

2020

11993

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.1

39.6

228

601

P28

ICPC

Limited function/disability (P)

3.0

39.5

238

647

SPAT1265

SPAT

Breathalyser

2.6

39.4

301

948

N06AX05

ATC

trazodone; oral

1.9

39.3

626

2757

UGC02

NOMESCO Finland

Rigid bronchoscopy

6.3

39.3

110

143

M25.5

ICD-10 Finland

Pain in joint

1.2

39.2

7593

53788

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.5

39.1

334

1121

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

2.7

39.0

276

831

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

5.4

39.0

123

186

N06AG02

ATC

moclobemide; oral

1.6

39.0

1025

5265

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.8

38.9

3309

33847

K02.2

ICD-10 Finland

Caries of cementum

1.7

38.8

882

4351

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.2

38.8

5166

35192

F05.8

ICD-10 Finland

Other delirium

4.8

38.7

137

236

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

7.1

38.7

100

116

N03AX18

ATC

lacosamide; systemic

3.3

38.7

207

517

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.4

38.7

197

474

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

38.6

1304

7118

4809X

ICD-9 Finland

Viral pneumonia, unspecified

+∞

38.6

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2.6

38.5

300

957

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

38.5

1066

5547

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.0

38.4

493

2000

Z00.8

ICD-10 Finland

Other general examinations

1.4

38.4

1654

9508

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

5.3

38.4

124

193

602

Kela drug reimbursment

Children's severe malnutrition

5.2

38.3

126

200

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

6.0

38.3

112

154

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

4.8

38.3

136

235

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

4.2

38.3

154

302

U07

ICPC

Urine symptom/complaint other

1.6

38.3

1103

5800

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

6.3

38.2

108

142

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.7

38.1

893

4447

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

3.6

38.0

185

429

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

5.3

38.0

123

192

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

3.3

38.0

200

494

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

37.9

563

2416

H3601, E103

ICD-10 Finland

2.5

37.9

303

981

R4130

NOMESCO Finland

Speech therapy

2.1

37.9

453

1785

C02CA01

ATC

prazosin; oral

3.4

37.8

193

465

D07XC01

ATC

betamethasone, combinations; topical

1.3

37.8

2648

16572

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.2

37.8

211

544

L29

ICPC

Musculoskeletal sympt/complt other

1.4

37.8

1634

9399

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

37.7

1649

9505

C08DA01

ATC

verapamil; systemic

1.8

37.7

740

3495

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.9

37.7

603

2658

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

2.6

37.7

284

889

A02BA04

ATC

nizatidine; systemic

1.5

37.7

1478

8335

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

37.7

7074

49927

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

37.5

1193

6420

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

8.7

37.5

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

37.5

709

3310

C07AB03

ATC

atenolol; systemic

1.7

37.5

864

4281

I20.00

ICD-10 Finland

Unstable angina

2.2

37.4

386

1423

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

6.3

37.4

105

137

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

6.7

37.4

100

122

M01AX17

ATC

nimesulide; oral

1.2

37.4

5598

38606

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

4.8

37.4

132

227

29580

ICD-8 Finland

Schizophrenia, Other

4.1

37.4

155

313

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.9

37.3

240

680

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

7.2

37.3

108

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.4

37.3

327

1113

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.3

37.3

367

1325

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

10289

50737

1.58

321.38

3.7

2.8

mmol/l

2.5

2.4

80.33

8925

44296

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2576

8147

2.35

316.64

3.3

2.7

g/l

3.8

3.5

19.72

2466

7767

(3013707) Erythrocyte sedimentation rate by Westergren method

35930

226834

1.44

310.19

5.6

3.7

mm/h

16.7

10.7

307.65

33620

210064

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

9315

29055

2.60

307.65

5.1

3.9

u/l

249.5

240.5

5.13

8885

27418

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3609

11917

2.28

307.65

4.2

2.8

1.4

1.3

7.46

3592

11856

(3018405) Lactate [Moles/volume] in Arterial blood

2934

8616

2.55

307.65

5.8

3.7

mmol/l

1.4

0.04

2871

8481

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2447

2081

8.86

307.65

1.8

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

5628

16353

2.66

307.65

9.4

7.1

mmol/l

25.2

24.6

18.09

5570

16228

(3006504) Eosinophils/100 leukocytes in Blood

29113

138101

2.15

307.65

9.0

5.5

2.6

2.9

97.93

27685

128415

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2751

8872

2.31

307.65

3.0

2.0

g/l

3.3

3.0

29.26

2158

6864

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2919

9386

2.32

307.65

3.0

1.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

2228

5634

2.94

307.65

2.7

2.0

g/l

126.9

132.7

17.83

1633

4150

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3545

7275

3.70

307.65

3.9

3.2

u/ml

0.3

0.4

4.98

2142

4013

(3030467) Casts [#/volume] in Urine by Automated count

17654

78991

1.92

307.65

4.1

2.9

e6/l

0.6

0.4

13.21

14055

58222

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

5030

15995

2.41

307.65

12.2

8.3

1.5

1.3

11.82

4989

15899

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1066

706

11.12

307.65

1.7

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

10588

39588

2.16

307.65

3.3

2.3

g/l

2.2

2.4

93.43

9852

36499

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

22483

106536

1.91

307.65

5.0

3.0

ng/l

81.3

59.5

0.90

16825

67319

(3008757) Leukocyte morphology finding [Identifier] in Blood

1276

2488

3.77

307.65

4.4

3.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

7667

23240

2.62

307.65

10.6

7.2

g/l

120.0

122.6

20.47

7420

22410

(3047181) Lactate [Moles/volume] in Blood

2515

7616

2.46

307.65

7.9

4.7

mmol/l

1.4

1.3

3.14

2252

6690

(3019069) Monocytes/100 leukocytes in Blood

29261

138927

2.16

307.65

9.4

5.8

8.6

8.5

5.32

27903

129889

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

4490

6346

5.49

307.65

3.0

2.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

2027

5535

2.71

307.65

1.7

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1951

3586

4.05

307.65

4.0

2.7

u/ml

1696.5

6119.5

0.68

142

172

(3024891) Influenza virus A+B Ag [Presence] in Specimen

3078

6059

3.84

307.65

1.3

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

752

377

14.61

307.65

1.6

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3497

11720

2.24

307.65

4.2

2.8

0.7

0.56

3398

11196

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

21057

118221

1.48

307.65

2.2

1.9

pmol/l

92.4

97.1

38.59

11844

61351

(3020779) Urea [Moles/volume] in Serum or Plasma

8061

22135

2.92

307.65

10.9

6.6

mmol/l

10.7

9.0

73.25

7718

21053

(3024561) Albumin [Mass/volume] in Serum or Plasma

25648

123286

1.97

307.65

6.9

4.4

g/l

33.7

36.2

307.65

24000

114207

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1328

828

11.87

307.65

1.2

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

3088

10166

2.27

307.65

6.9

4.1

1.8

1.7

6.61

2893

9561

(3022313) Gas panel - Capillary blood

4472

11552

2.96

307.65

6.3

3.3

—

(3020891) Body temperature

3169

10115

2.35

307.65

7.3

4.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1623

1419

8.50

307.65

4.1

3.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

677

7.31

307.65

2.3

1.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

5885

13836

3.33

307.65

1.7

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

7667

22132

2.76

307.65

8.9

6.6

mmol/l

1.4

1.3

5.70

7294

21424

(3028026) IgM [Mass/volume] in Serum or Plasma

5159

15649

2.53

307.65

2.1

1.7

g/l

1.2

1.3

1.63

4695

14302

(3026493) Urate [Moles/volume] in Serum or Plasma

14581

77358

1.50

307.65

3.8

2.4

umol/l

3324.2

4371.3

2.85

12763

67412

(3012501) Base excess in Blood by calculation

2520

5432

3.47

307.65

5.9

2.9

mmol/l

2.8

2.3

13.23

1887

3478

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

3145

8778

2.69

307.65

1.8

1.6

titre

341.5

260.3

0.75

149

348

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

5046

12482

3.12

307.65

10.7

9.1

mmol/l

24.7

24.1

27.50

4642

11760

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

684

691

7.24

307.65

2.3

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2847

5730

3.74

307.65

4.4

2.5

mmol/l

25.2

24.3

18.86

2510

5054

(3032080) INR in Blood by Coagulation assay

24578

112652

2.07

307.65

12.1

7.5

inr

1.3

1.2

6.96

7349

32963

(3042631) Mycobacterium sp identified in Specimen

1804

2593

5.17

307.65

3.1

2.2

—

(3023368) Bacteria identified in Blood by Culture

26513

62658

5.09

307.65

5.9

3.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

10477

42033

2.00

307.65

2.9

2.0

30.4

29.7

19.91

10171

40848

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

4044

10904

2.82

307.65

1.9

1.6

g/l

1.7

1.5

22.65

3486

9255

(44790049)

1786

1916

6.94

307.65

1.8

1.4

—

(44806118)

1786

1917

6.93

307.65

1.8

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

6619

23201

2.21

307.65

5.2

3.8

1.0

0.9

0.70

2637

5504

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

7720

32526

1.84

307.65

3.4

2.7

umol/l

8.3

8.5

0.34

6627

28223

(3021901) Oxygen saturation in Capillary blood

2174

4043

4.01

307.65

3.8

2.3

—

(4062490)

1249

2551

3.60

307.65

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

6462

20249

2.49

307.65

3.6

2.4

g/l

10.2

10.7

9.24

5972

18460

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

2353

1834

9.66

307.65

1.5

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1576

2941

3.96

307.65

7.4

5.8

mg/l

11.7

11.1

4.55

1439

2720

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

14452

62671

1.91

307.65

2.2

1.7

mg/l

1.4

1.1

12.03

11584

46753

(3025159) Blasts/100 leukocytes in Blood

5615

21299

2.01

307.65

5.3

3.9

0.0

0.3

4.46

2057

4369

(3019198) Lymphocytes [#/volume] in Blood

30964

152506

2.11

307.65

8.7

5.4

e9/l

1.9

2.0

8.88

27833

134171

(3018095) Leukocytes [#/volume] in Urine

21262

102639

1.83

307.65

5.0

3.4

e6/l

90.5

94.9

0.30

16367

70579

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1436

1411

7.53

307.65

1.9

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

2314

5086

3.39

307.65

3.3

2.1

15.9

16.9

22.14

1245

2579

(3012095) Magnesium [Moles/volume] in Serum or Plasma

12782

42602

2.54

307.65

5.0

3.2

mmol/l

0.8

32.65

12011

39721

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1650

3884

3.14

307.65

3.3

3.0

nmol/l

0.8

4.38

1256

2982

(3027135) IgG subclass 1 [Mass/volume] in Serum

1245

2552

3.59

307.65

1.4

g/l

6.7

0.00

902

1721

(3018418) pH of Serum or Plasma

18118

82650

1.89

307.65

6.2

3.6

7.4

3.06

3942

15443

(3037467) Urinalysis macro (dipstick) panel - Urine

34973

208902

1.61

307.65

5.8

3.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1650

1997

6.13

307.65

1.9

1.5

—

(40768806) Pleura Pathology biopsy report

1251

1842

5.00

307.65

1.5

—

(1616796) Gas panel - Central venous blood

2664

5124

3.90

307.65

5.0

2.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

11682

49423

1.91

307.65

1.9

1.7

nmol/l

1174.0

1165.7

0.39

9036

37268

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

5032

15960

2.41

307.65

12.3

8.4

0.7

1.49

4994

15876

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

12387

22975

4.77

307.65

2.2

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

2276

5088

3.33

307.65

2.9

2.8

umol/l

33.3

34.5

1.14

1946

4309

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

4949

7445

5.20

307.65

2.3

1.8

ug/l

2.3

0.06

4457

6499

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1648

2449

4.99

307.65

1.2

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

32961

172136

2.00

307.65

7.7

4.0

mmol/l

6.9

6.6

94.19

31514

159573

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

853

875

7.15

307.65

2.1

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

5751

13557

3.32

307.65

2.0

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3024

2670

8.62

307.65

1.6

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

11230

43292

2.11

307.65

3.4

2.3

umol/l

11.5

14.3

8.58

10462

40086

(3003434) Protein [Mass/volume] in Pleural fluid

1691

2283

5.50

307.65

1.5

1.4

g/l

32.8

33.9

2.09

1524

2089

(3026782) Osmolality of Urine

13717

54200

2.12

307.65

3.5

2.5

mosm/kgh2o

526.7

554.7

38.09

12127

45645

(3006315) Basophils [#/volume] in Blood

30529

148174

2.14

307.65

8.6

5.4

e9/l

0.0

0.01

27062

127839

(3001122) Ferritin [Mass/volume] in Serum or Plasma

22863

132397

1.43

307.65

3.6

2.7

ug/l

173.4

113.2

75.20

21215

123099

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3622

3058

9.11

307.65

1.4

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

852

880

7.10

307.65

2.1

1.7

—

(40758558) Short blood count panel - Blood

16152

73718

1.84

307.65

10.4

6.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

3035

6243

3.67

307.65

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3623

3059

9.11

307.65

1.4

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

6667

25813

1.99

307.65

2.5

2.2

nmol/l

357.7

376.2

8.93

6141

23814

(3024139) IgG subclass 3 [Mass/volume] in Serum

1244

2549

3.59

307.65

1.4

g/l

0.4

0.57

905

1725

(3007853) Bacteria identified in Skin by Aerobe culture

8968

32993

2.16

307.65

2.2

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

6299

20302

2.41

307.65

3.8

2.5

ng/l

264.0

170.3

34.08

5806

18337

(3011412) CD3 cells [#/volume] in Blood

1275

2257

4.16

307.65

2.5

e9/l

1.2

0.53

777

1327

(3004809) Band form neutrophils/100 leukocytes in Blood

1824

3654

3.70

307.65

3.9

2.9

1.5

1.4

0.63

1448

2803

(3002179) Metamyelocytes/100 leukocytes in Blood

5965

21220

2.16

307.65

4.9

3.7

0.7

0.6

0.47

1891

4010

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

4725

12326

2.94

307.65

6.0

4.2

mmol/l

24.4

24.0

10.82

4302

11093

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2632

7039

2.79

307.65

1.6

1.4

iu/ml

18.4

11.7

1.34

141

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2524

4719

4.01

307.65

7.8

5.0

iu/ml

3071.1

741.9

0.88

444

613

(3028271) Lactate [Moles/volume] in Capillary blood

1786

3742

3.54

307.65

2.4

1.6

mmol/l

1.6

1.8

9.58

1747

3656

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

27025

127745

2.07

307.65

10.0

5.2

mmol/l

1.2

132.62

25083

115261

(3034860) Kappa light chains.free [Mass/volume] in Serum

2630

7371

2.66

307.65

4.3

2.8

mg/l

75.1

61.7

0.39

2105

5983

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1875

4610

3.01

307.65

1.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1870

4934

2.80

307.65

1.3

1.2

titre

176.3

114.8

0.53

(3013290) Carbon dioxide [Partial pressure] in Blood

2521

5433

3.47

307.65

5.9

2.9

kpa

5.1

5.0

6.44

2469

5313

(3009445) Proteinase 3 Ab [Units/volume] in Serum

4085

10989

2.83

307.65

1.7

1.5

u/ml

13.7

15.2

0.25

125

298

(3028192) IgG subclass 2 [Mass/volume] in Serum

1245

2550

3.59

307.65

1.4

g/l

2.7

3.1

10.61

901

1721

(3023520) Reticulocytes [#/volume] in Blood

6321

21319

2.30

307.65

3.2

2.5

e9/l

72.1

69.0

7.79

4813

15973

(3036782) Glucose [Moles/volume] in Pleural fluid

1178

1643

5.28

307.65

1.4

1.3

mmol/l

6.4

6.2

1.12

1081

1534

(3008152) Bicarbonate [Moles/volume] in Arterial blood

5111

14991

2.62

307.65

9.9

6.1

mmol/l

25.1

24.4

24.53

4813

13940

(40760888) Immunoglobulin light chains.free panel - Serum

2093

5387

2.88

307.65

4.3

2.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1499

804

13.84

307.65

1.9

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

6146

22287

2.12

307.65

5.3

3.9

0.1

1.46

2435

5106

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1572

1752

6.65

307.65

2.0

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1586

3817

3.07

307.65

5.9

4.9

umol/l

371.7

369.7

0.18

1384

3320

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1176

801

10.83

307.65

1.6

1.2

—

(3042936) Bacteria identified in Isolate by Culture

11268

37794

2.46

307.65

2.5

1.9

—

(3000494) Fungus identified in Specimen by Culture

7860

33143

1.84

307.65

1.9

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2733

8741

2.33

307.65

2.9

2.0

g/l

10.2

0.30

2299

7292

(3012441) Differential panel - Pleural fluid

1324

1782

5.48

307.65

1.5

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5971

22081

2.08

307.65

2.7

2.1

ug/l

7.4

7.3

0.14

5119

19358

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6407

26333

1.86

307.65

3.0

2.4

u/l

54.7

42.8

0.46

5479

22577

(3028308) Erythrocytes [#/volume] in Pleural fluid

1376

1879

5.41

307.65

1.5

1.4

e6/l

44348.3

60037.7

1.07

861

1103

(3003458) Phosphate [Moles/volume] in Serum or Plasma

10805

34057

2.62

307.65

8.8

5.2

mmol/l

1.1

1.0

18.73

10167

31782

(3037756) Immunofixation for Serum or Plasma

1893

4631

3.03

307.65

1.9

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

10083

36539

2.23

307.65

3.5

2.3

20.7

23.6

69.08

8730

31329

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

29062

141671

2.06

307.65

11.1

5.7

mmol/l

1.2

104.12

24806

119144

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

18916

98430

1.60

307.65

4.1

3.0

u/l

36.5

33.0

2.50

17972

93306

(36304419) Bacteria [Presence] in Urine

17147

77231

1.89

307.65

4.1

2.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

6149

15068

3.20

307.65

5.7

3.2

mmol/l

2.1

1.4

41.06

4779

10777

(3027801) Oxygen [Partial pressure] in Arterial blood

9978

27284

3.02

307.65

9.2

6.7

kpa

10.9

13.3

307.65

9444

26181

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3320

8554

2.93

307.65

2.8

2.2

ug/l

630.3

498.9

0.64

3132

7968

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

3776

3811

7.63

307.65

1.9

1.5

—

(44790047)

1786

1917

6.93

307.65

1.8

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3922

3896

7.78

307.65

1.9

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

2813

5962

3.55

307.65

5.5

3.5

kpa

8.1

8.7

56.81

2626

5582

(3027273) Bicarbonate [Moles/volume] in Venous blood

3729

12020

2.34

307.65

5.0

3.0

mmol/l

25.4

25.1

4.66

3611

11679

(42870588) Differential panel, method unspecified - Blood

23192

98255

2.25

307.65

8.3

5.5

—

(3010421) pH of Blood

2798

6330

3.32

307.65

5.9

2.9

7.4

1.07

2472

5314

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2517

2019

9.41

307.65

1.6

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

16055

69942

1.94

307.65

2.6

2.2

mg/l

3.2

2.9

50.08

13975

59642

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

6902

17460

3.13

307.65

2.0

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

4458

15508

2.18

307.65

4.9

3.1

g/l

124.5

131.2

63.66

4347

15184

(3021447) Carbon dioxide [Partial pressure] in Venous blood

8133

23523

2.77

307.65

5.6

3.7

kpa

5.9

5.8

15.91

7832

22957

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

936

1205

5.70

307.65

1.3

u/l

15.0

13.0

0.98

852

1134

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

678

677

7.32

307.65

2.3

1.8

—

(3035880) pH of Pleural fluid

747

860

6.36

307.65

1.2

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

5020

16815

2.28

307.65

3.0

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2998

9999

2.24

307.65

7.0

4.1

0.9

1.18

2814

9396

(3019060) Gas panel - Arterial blood

6230

14846

3.30

307.65

6.0

4.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

29709

143554

2.12

307.65

9.1

5.6

24.9

29.1

307.65

28236

133491

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2912

9369

2.32

307.65

3.0

1.9

g/l

3.9

3.8

0.64

2128

6660

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

17763

86042

1.74

307.65

2.7

2.0

u/l

267.9

199.1

6.82

16750

80647

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3668

9044

3.07

307.65

2.3

1.6

—

(3018010) Neutrophils/100 leukocytes in Blood

29189

141531

2.08

307.65

8.7

5.4

59.9

56.2

307.65

27780

132240

(3013650) Neutrophils [#/volume] in Blood by Automated count

33494

171731

2.10

307.65

14.1

8.1

e9/l

4.7

4.0

307.65

30075

149216

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

746

771

7.08

307.65

4.3

3.2

—

(3022096) Basophils/100 leukocytes in Blood

28530

133652

2.17

307.65

8.9

5.6

0.6

0.7

155.08

27167

124309

(3013115) Eosinophils [#/volume] in Blood

31235

153229

2.14

307.65

9.2

5.6

e9/l

0.2

1.19

28002

134303

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

10315

45081

1.81

307.65

3.6

2.7

e6/l

3.0

2.8

0.79

5826

23983

(3009343) pH of Capillary blood

6312

15617

3.18

307.65

5.8

3.2

7.4

0.31

929

1863

(3003396) Base excess in Arterial blood by calculation

9958

27323

3.01

307.65

9.2

6.7

mmol/l

1.6

0.7

64.46

8077

21367

(3027315) Oxygen [Partial pressure] in Blood

2539

5462

3.48

307.65

5.9

2.9

kpa

8.3

8.9

35.09

2486

5342

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6879

25688

2.07

307.65

2.5

2.3

g/l

0.2

43.06

6325

23985

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2922

7296

3.01

307.65

1.9

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

10629

48769

1.72

307.65

3.4

2.6

e6/l

1.4

1.1

0.71

6113

27501

(3044640) Blood type and Crossmatch panel - Blood

17881

93128

1.58

307.65

3.3

2.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

12346

22936

4.76

307.65

2.1

1.5

—

(3000850) Epithelial cells [#/volume] in Urine

14272

58780

2.03

307.65

3.4

2.4

e6/l

6.0

5.5

4.33

12843

50846

(3001604) Monocytes [#/volume] in Blood

30418

147442

2.14

307.65

8.6

5.4

e9/l

0.6

248.37

26955

127277

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5168

19950

1.97

307.65

5.3

3.6

ng/l

111.2

83.5

46.54

4507

17251

(3031040) Bacteria [#/volume] in Urine by Automated count

34962

195725

1.84

307.65

6.0

4.0

e6/l

1160.8

1432.7

0.47

670

2524

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

853

875

7.15

307.65

2.1

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

4085

9794

3.18

307.65

2.6

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2922

9396

2.32

307.65

3.0

1.9

g/l

7.7

7.3

20.17

2206

7018

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1436

1411

7.53

307.65

1.9

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

2887

4154

5.26

307.65

1.7

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2631

7355

2.67

307.65

4.3

2.8

mg/l

49.1

41.1

1.20

2101

5979

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

9982

27300

3.02

307.65

9.2

6.7

kpa

5.2

5.1

14.05

9465

26192

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

3046

2719

8.53

307.65

1.9

1.5

—

(3023419) Bacteria identified in Sputum by Culture

2095

1858

8.44

307.65

3.1

1.8

—

(3033658) Prothrombin time (PT) actual/Normal

15554

74167

1.73

307.65

5.9

3.6

86.8

91.7

94.12

15142

72309

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

853

875

7.15

307.65

2.1

1.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

6482

19708

2.57

307.65

4.8

3.2

kpa

4.8

4.6

5.01

6186

19178

(3002582) Erythrocytes [#/volume] in Urine

19329

86141

1.98

307.65

4.3

3.0

e6/l

79.4

86.7

0.25

15689

64805

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

6381

15822

3.18

307.65

5.8

3.2

kpa

5.2

5.1

17.54

5964

14607

(3014576) Chloride [Moles/volume] in Serum or Plasma

9369

33043

2.27

307.65

10.0

6.3

mmol/l

103.8

104.7

47.85

9094

32404

(44790048)

1786

1918

6.93

307.65

1.8

1.4

—

(3021589) Normoblasts [#/volume] in Blood

24482

134899

1.58

307.65

14.8

8.5

e9/l

0.0

0.56

20271

110786

(3002032) Base excess in Venous blood by calculation

8140

23400

2.79

307.65

5.6

3.7

mmol/l

2.2

1.7

22.73

6775

19073

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1356

1167

8.59

307.65

1.7

1.2

—

(3000991) Gas panel - Venous blood

7379

21680

2.70

307.65

10.9

7.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1194

1520

5.79

307.65

1.3

u/l

594.9

378.1

2.07

1136

1447

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

13718

70787

1.54

307.65

3.2

2.1

—

(3012544) pH of Venous blood

8324

24383

2.74

307.65

5.5

3.7

7.4

0.17

124

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

12728

51960

2.01

307.65

5.0

3.2

ng/l

408.1

538.4

2.03

10272

37970

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

2556

2273

8.49

307.65

1.6

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

5065

16052

2.42

307.65

12.3

8.4

92.7

94.4

56.89

5037

16002

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3385

11328

2.24

307.65

5.6

3.4

51.1

47.9

10.43

3340

11210

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

30762

149862

2.14

307.65

8.7

5.5

umol/l

10.9

11.6

11.50

29426

141451

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

956

1286

5.45

307.65

1.5

1.4

u/l

12.8

12.3

0.94

918

1254

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18393

73723

2.23

307.65

4.0

2.7

ng/l

2055.0

1090.1

85.95

16235

61846

(3027945) Reticulocytes/100 erythrocytes in Blood

8546

28782

2.37

307.65

3.3

2.4

1.9

1.7

34.10

7622

25512

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2569

7124

2.69

307.65

4.2

2.8

ratio

6.3

2.7

0.72

203

574

(3026008) Bacteria identified in Urine by Culture

18195

82146

1.91

307.65

3.8

2.8

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1478

2994

3.64

307.65

2.3

1.6

89.1

90.4

11.68

1460

2946

(3015377) Calcium [Moles/volume] in Serum or Plasma

18547

96678

1.59

307.65

4.4

3.1

mmol/l

2.3

2.4

48.79

16374

84459

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

2003

1759

8.52

307.65

1.9

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

12974

64597

1.60

307.65

1.7

1.5

nmol/l

19.2

20.6

21.03

11457

55220

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6916

27842

1.91

307.65

4.8

2.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

19253

91275

1.82

307.65

3.3

2.4

u/l

54.8

59.0

13.43

18021

83876

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4358

13431

2.47

307.65

12.8

8.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1436

1411

7.53

307.65

1.9

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

1509

2073

5.39

307.65

1.5

1.4

e6/l

4477.3

2766.0

1.15

1122

1482

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

39029

231950

1.80

307.65

11.6

6.6

u/l

83.4

77.1

98.19

37454

217744

(3016502) Oxygen saturation in Arterial blood

8776

24614

2.89

307.65

9.7

7.0

94.4

96.2

103.33

8441

23744

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1065

691

11.35

307.65

1.7

1.2

—

(3045788) Cell count panel - Pleural fluid

1137

1596

5.24

307.65

1.6

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

6511

20308

2.50

307.65

3.1

2.3

g/l

65.0

67.1

76.37

5987

18432

(3022217) INR in Platelet poor plasma by Coagulation assay

8793

34299

2.02

307.65

27.1

22.1

inr

1.4

1.3

8.36

1216

4999

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3739

10459

2.70

307.65

6.8

3.4

mmol/l

25.1

24.6

15.27

3532

9693

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

17184

34956

4.77

307.65

2.3

1.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

986

1825

3.96

303.72

2.1

2.2

72.2

72.5

0.18

949

1765

(3024980) IgG subclass 4 [Mass/volume] in Serum

1650

4274

2.85

302.57

1.6

g/l

0.7

0.8

0.91

1241

3212

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

973

1796

3.97

300.80

2.0

2.2

13.4

13.9

0.38

467

880

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

568

643

6.44

299.34

2.0

1.5

u/ml

27981.5

26830.0

0.02

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2497

7997

2.32

297.98

3.1

2.1

g/l

0.9

0.8

0.94

2144

6871

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

931

1681

4.06

296.22

2.1

2.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

911

1623

4.11

294.90

19.4

18.8

nmol/l

2323.2

2887.4

0.17

872

1553

(3043409) Potassium [Moles/volume] in Arterial blood

2389

7555

2.35

293.27

6.5

3.9

mmol/l

3.9

0.76

2189

7158

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

919

1658

4.06

292.70

2.5

2.6

e6/l

610.2

494.2

2.01

781

1363

(40760892) CBC W Ordered Manual Differential panel - Blood

12815

67558

1.49

289.64

6.5

4.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

890

1604

4.06

283.83

2.6

e9/l

0.2

0.04

781

1358

(3024928) Oxygen saturation in Venous blood

1850

5264

2.60

283.76

4.2

3.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

468

451

7.56

282.55

1.3

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

865

1548

4.09

278.36

13.6

13.5

nmol/l

843.9

1454.3

0.47

841

1492

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

23893

142001

1.39

276.61

5.3

3.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

1050

2179

3.53

275.76

2.3

2.2

35.7

42.5

3.64

108

298

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2503

8313

2.23

273.97

1.9

1.6

g/l

0.2

1.19

2376

7893

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2226

7082

2.33

269.17

2.9

2.0

g/l

0.0

0.85

2030

6470

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2547

8583

2.20

269.09

1.9

1.6

g/l

1.2

1.23

2421

8181

(3010503) CD19 cells [#/volume] in Blood

789

1354

4.26

267.72

2.7

2.5

e9/l

0.5

0.2

1.33

767

1322

(3003181) Sodium [Moles/volume] in Urine

1543

4141

2.74

264.79

1.5

1.4

mmol/l

61.7

64.1

1.18

1179

3297

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

21113

123504

1.39

264.57

2.7

2.2

nmol/l

75.4

811.2

0.50

19158

111653

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2267

7329

2.29

264.17

2.8

2.0

g/l

36.1

38.4

49.20

1971

6265

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

918

1790

3.76

263.41

2.6

2.5

e6/l

782.2

695.8

0.31

390

677

(3017354) Segmented neutrophils/100 leukocytes in Blood

1066

2311

3.38

262.25

3.8

3.0

60.1

56.9

3.23

704

1476

(3008536) Aspergillus sp Ab [Presence] in Serum

378

303

9.08

261.59

2.1

2.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

4473

18628

1.80

259.53

1.5

1.3

u/ml

291.6

247.5

1.20

4128

17239

(40757373) Influenza virus identified in Isolate

349

251

10.11

259.53

1.8

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

8326

40920

1.56

256.83

1.4

1.3

titre

551.3

533.5

0.34

1842

7953

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1490

3991

2.75

256.56

1.6

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

2412

8110

2.20

255.95

4.1

2.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2070

6526

2.35

255.28

2.9

2.0

g/l

0.0

0.26

1878

5939

(3015736) pH of Urine

19839

115470

1.39

252.49

4.3

3.2

5.8

—

(3035350) Ketones [Presence] in Urine by Test strip

24708

149202

1.37

249.33

4.6

3.3

estimate

0.0

2.69

5433

27093

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2033

6441

2.33

247.84

2.9

2.0

g/l

0.0

0.00

1870

5923

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5170

22863

1.70

242.68

5.9

3.3

mmol/l

1.2

24.86

4711

19727

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6061

27963

1.64

242.17

3.9

4.1

ug/l

20.1

26.5

1.06

5039

22170

(4010399)

4713

20353

1.74

240.79

1.6

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

24885

151268

1.35

235.25

4.7

3.4

estimate

0.0

0.44

5353

27038

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2525

9013

2.08

229.81

3.3

2.4

90.6

92.4

3.42

2412

8332

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1834

5759

2.35

227.85

1.7

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

24604

149754

1.35

227.65

6.2

4.5

estimate

0.0

1.07

5572

27818

(3010375) cycloSPORINE [Mass/volume] in Blood

626

1021

4.47

225.96

33.9

25.4

ug/l

116.2

121.8

0.89

518

858

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1814

5713

2.34

223.83

1.6

1.4

u/ml

21.6

18.8

0.33

(46235355) HIV 1 and 2 tests - Meaningful Use set

10972

58565

1.45

222.78

2.0

1.9

—

(3019977) pH of Arterial blood

664

1154

4.20

221.74

2.8

2.4

7.4

0.73

227

393

(3026250) Tacrolimus [Mass/volume] in Blood

628

1051

4.36

219.75

40.9

34.3

ug/l

7.4

7.3

0.51

572

957

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1143

2891

2.90

218.21

2.0

1.9

ug/l

21.6

25.5

1.45

1118

2832

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2226

7727

2.13

217.57

5.3

4.1

mg/l

1.8

1.4

59.02

2059

7148

(4035726)

5381

24842

1.63

212.55

1.5

1.4

—

(3039000) Anion gap in Blood

1698

5322

2.35

211.66

9.4

5.5

mmol/l

11.3

11.2

0.36

1534

4806

(3018572) Chloride [Moles/volume] in Blood

1698

5323

2.35

211.57

9.4

5.5

mmol/l

104.4

105.4

10.85

1534

4808

(3017143) Hepatitis C virus Ab [Presence] in Serum

7322

36440

1.52

209.01

1.9

1.6

—

(3036489) Thrombin time

2807

10780

1.93

207.94

2.9

2.1

21.8

21.5

1.56

2522

9295

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

46312

313738

1.51

207.10

29.0

11.0

mg/l

33.6

21.3

307.65

42312

240275

(3007164) IgA [Mass/volume] in Serum or Plasma

11030

59727

1.42

204.34

1.8

1.4

g/l

2.5

2.3

11.35

7184

35999

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

934

2190

3.12

202.83

3.4

2.5

—

(3028433) Virus identified in Specimen by Culture

483

693

5.08

201.64

1.2

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2276

8239

2.04

198.97

3.2

2.6

203.3

180.9

24.49

2184

7789

(3013512) EKG study

14627

83397

1.37

198.69

4.8

3.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

400

487

5.98

197.17

1.3

mmol/l

3.4

3.6

0.40

366

456

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

449

621

5.26

194.91

1.4

56.1

66.0

5.35

361

520

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1653

5326

2.28

193.30

1.7

1.4

u/ml

114.7

108.2

0.65

319

1217

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

694

1388

3.65

192.11

1.6

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

681

1363

3.65

188.31

1.6

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1748

5835

2.21

187.89

1.4

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

11049

60604

1.40

187.72

1.8

1.6

pmol/l

19382745.3

33929889.8

2.46

9163

50325

(3017569) Oxygen content in Arterial blood

545

927

4.28

186.97

2.2

2.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2067

7438

2.05

183.37

2.0

mg/l

11.5

10.6

4.13

1928

6951

(4015189)

384

485

5.76

182.74

2.9

1.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

266

225

8.59

177.31

2.5

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

795

1835

3.16

177.10

1.5

1.2

u/ml

1.6

0.9

1.42

482

663

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1291

3872

2.45

176.92

1.8

1.6

—

(1761868) Lipid panel - Serum or Plasma

13143

118093

0.74

175.03

3.0

2.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2915

11966

1.81

174.78

2.0

u/l

38.4

39.8

2.89

2576

10692

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1638

5504

2.19

173.11

1.4

1.3

u/ml

290.4

255.3

4.45

1055

3497

(3040151) Glucose [Moles/volume] in Capillary blood

1043

2849

2.68

172.66

16.4

4.7

mmol/l

7.4

7.3

0.45

893

2307

(3009508) Creatinine [Moles/volume] in Urine

15864

93091

1.33

172.66

3.9

3.2

mmol/l

7.3

8.0

5.19

13430

78590

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

557

1030

3.94

171.71

3.9

2.9

—

(3046861) Legionella sp Ag [Presence] in Urine

146

28.61

170.53

1.1

1.0

—

(21494755) Public health laboratory ask at order entry panel

2977

35479

0.58

168.09

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

15229

89313

1.33

164.52

4.6

3.9

mg/mmol

16.5

7.8

42.16

10316

56084

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

641

1356

3.45

163.53

2.8

37.6

39.9

1.32

226

422

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

206

135

11.07

162.25

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2287

8904

1.90

161.76

1.7

1.6

iu/ml

3.2

7.4

0.60

546

1810

(3037121) Protein [Mass/volume] in Urine

2411

9554

1.86

161.52

3.9

3.2

g/l

0.4

0.3

2.55

1266

4188

(3044242) Glucose [Moles/volume] in Arterial blood

535

1008

3.87

160.87

2.3

1.8

—

(3012516) Albumin [Mass/volume] in Urine

14531

84930

1.33

159.68

3.8

3.2

mg/l

565.7

367.2

4.72

10041

53078

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

548

1058

3.77

159.39

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

547

1058

3.77

158.70

1.6

1.3

—

(3000492) Spirometry study

5842

29299

1.50

156.99

1.7

1.4

—

(3042733) HLA Ab [Presence] in Serum

478

844

4.12

156.51

5.2

4.8

—

(3029937) Albumin [Presence] in Urine by Test strip

13791

80221

1.33

155.88

5.3

3.7

estimate

0.0

1.28

5146

26912

(3016228) CD19 cells/100 cells in Blood

498

913

3.97

155.31

2.1

2.0

9.0

8.5

0.38

487

889

(3006245) CD3-CD19+ cells/100 cells in Blood

513

962

3.88

155.25

2.1

2.5

11.5

11.0

0.25

477

911

(21494814) CD8 cells/100 lymphocytes in Specimen

487

893

3.97

151.85

2.1

2.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2393

9645

1.83

151.76

1.4

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

252

244

7.50

151.69

1.4

1.1

—

24.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2679

31987

0.58

151.13

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1660

5913

2.06

150.95

1.6

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

312

391

5.80

149.67

1.4

26.6

19.7

2.78

257

341

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1322

4352

2.23

146.64

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4765

23201

1.53

146.60

1.5

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

495

944

3.82

146.45

2.0

2.4

29.7

28.2

1.28

470

908

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3319

14847

1.66

145.78

3.5

2.5

e6/l

0.3

1.79

3255

14427

(3050794) Legionella sp Ab [Presence] in Serum

182

120

11.00

142.86

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

12052

69527

1.33

141.68

4.4

3.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

168

12.31

140.57

1.9

1.6

umol/l

49.0

45.3

0.51

168

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1990

7747

1.89

140.46

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

407

698

4.24

138.29

2.1

2.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

358

555

4.69

137.25

1.3

1.4

2.7

0.01

297

474

(3001964) Herpes simplex virus Ag [Presence] in Specimen

401

685

4.26

136.93

1.9

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

405

707

4.17

134.60

3.2

3.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

328

487

4.89

132.04

1.3

ug/l

129.5

378.4

1.59

186

251

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2083

8409

1.82

131.08

1.3

1.4

—

(3013727) Leukocytes other/100 leukocytes in Blood

396

695

4.14

130.73

4.3

3.0

55.4

50.9

2.94

385

672

(21494890) Protein electrophoresis panel - 24 hour Urine

862

2467

2.55

130.10

2.5

1.8

—

(3019225) pH of Specimen

5462

27987

1.46

130.04

6.7

3.6

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

792

2187

2.64

128.35

1.2

titre

240.0

134.2

0.68

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

793

2194

2.64

128.03

1.2

titre

187.2

200.4

0.16

131

373

(3035947) Staphylolysin Ab [Units/volume] in Serum

541

1212

3.25

126.46

1.2

1.1

iu/ml

4.2

3.7

0.33

(3045142) Bone marrow Pathology biopsy report

903

2692

2.45

125.22

1.4

1.3

—

(3051651) Icteric interference index of Serum or Plasma

619

1515

2.98

125.09

4.9

3.6

—

(3025941) Bacteria identified in Stool by Culture

3629

17232

1.56

123.98

1.4

1.2

—

(3008295) Osmolality of Serum or Plasma

859

2516

2.49

123.63

1.4

1.5

mosm/kgh2o

278.2

280.5

1.56

661

1968

(3019230) Fractional oxyhemoglobin in Venous blood

1301

4578

2.08

121.99

4.7

3.2

65.2

65.1

0.03

1294

4560

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

335

544

4.47

121.71

1.3

1.2

—

(40768797) Stomach Pathology biopsy report

7442

40785

1.37

120.04

1.3

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

501

1105

3.30

120.03

2.1

1.9

umol/l

132.3

141.4

0.20

242

559

(3014891) Appearance of Pleural fluid

199

193

7.48

119.70

1.7

1.5

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

319

506

4.58

119.16

1.3

1.4

27.0

18.4

4.82

289

461

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

505

1125

3.27

119.12

1.3

1.1

—

(3024471) HLA-A [Type]

435

878

3.60

118.97

1.0

—

(40761536) Microorganisms panel - Urine sediment

4983

25556

1.45

117.29

5.4

3.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

1075

3563

2.21

117.21

1.7

1.5

—

(3017704) Immunofixation for Urine

514

1173

3.19

116.70

1.9

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

391

743

3.83

116.33

2.0

2.5

e6/l

829.4

642.4

0.16

238

396

(3024932) HLA-DR beta [Type]

426

862

3.59

116.10

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

233

284

5.95

114.89

1.7

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

144

11.22

114.46

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1990

8250

1.77

114.46

1.4

ug/g

259.2

279.5

4.02

1175

4729

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1061

3542

2.19

113.67

1.7

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

738

2100

2.56

112.71

2.2

1.9

g/24h

1.1

1.0

0.11

129

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1030

3419

2.20

111.89

1.7

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1038

3457

2.19

111.85

1.7

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1028

3416

2.20

111.38

1.7

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1027

3414

2.20

111.17

1.7

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1188

4185

2.08

111.03

1.3

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1732

21471

0.57

110.76

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

772

2266

2.48

110.63

2.5

2.4

0.2

0.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5243

51287

0.71

110.49

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1034

3459

2.18

110.21

1.7

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

145

101

10.41

110.14

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

255

356

5.20

109.79

3.4

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1795

7312

1.80

109.42

1.5

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

563

1415

2.90

108.68

2.6

2.5

u/ml

1332.2

910.2

2.50

556

1401

(40768446) Kidney Pathology biopsy report

462

1035

3.25

108.06

1.8

1.7

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

175

167

7.60

106.66

1.6

1.7

mg/l

1.9

1.6

0.27

116

112

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

172

161

7.75

106.43

1.6

1.7

mg/l

3.5

4.2

0.53

116

103

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

172

161

7.75

106.43

1.6

1.7

mg/l

2.3

2.2

0.04

113

108

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

172

161

7.75

106.43

1.6

1.7

mg/l

1.0

1.4

0.44

114

103

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

172

161

7.75

106.43

1.6

1.7

mg/l

2.6

2.9

0.23

117

112

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

172

161

7.75

106.43

1.6

1.7

mg/l

1.4

2.0

0.67

104

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

172

161

7.75

106.43

1.6

1.7

mg/l

2.0

1.7

0.29

131

120

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

172

161

7.75

106.43

1.6

1.7

mg/l

1.3

0.8

0.78

111

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

172

161

7.75

106.43

1.6

1.7

mg/l

2.9

2.7

0.06

119

118

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

172

161

7.75

106.43

1.6

1.7

mg/l

1.8

1.5

0.38

124

115

(3019550) Sodium [Moles/volume] in Serum or Plasma

46132

318845

1.34

106.27

30.8

12.9

mmol/l

139.1

139.7

307.65

45266

310456

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

353

668

3.84

105.67

3.2

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

353

668

3.84

105.67

3.2

2.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

40570

309025

0.79

104.66

4.5

4.2

mmol/l

1.4

1.5

237.24

37278

287190

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

670

1888

2.59

104.37

2.3

1.6

mg/l

4.8

3.4

7.89

632

1804

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

882

2855

2.25

101.75

1.3

1.1

—

(3044927) Protein electrophoresis panel - Urine

764

2322

2.40

101.66

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1167

4220

2.02

101.65

1.1

—

(3045716) Anion gap in Serum or Plasma

458

1067

3.12

100.62

2.6

2.3

mmol/l

8.8

9.4

2.24

355

764

(3023103) Potassium [Moles/volume] in Serum or Plasma

46199

319816

1.33

100.54

31.0

13.0

mmol/l

4.0

36.41

45250

310803

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

18526

116501

1.23

99.13

5.0

3.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

909

3018

2.20

98.69

1.2

—

(40761535) Cells panel - Urine sediment

4510

23405

1.43

98.66

4.5

3.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

177

189

6.79

98.40

1.3

31.0

18.7

3.44

137

143

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

40963

311194

0.79

98.04

4.6

4.2

mmol/l

4.5

4.7

312.68

37835

290463

(3000093) Morphology [Interpretation] in Blood Narrative

789

2492

2.31

96.37

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

944

3219

2.14

95.93

2.4

2.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

8487

48915

1.30

94.62

1.8

1.6

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

959

3310

2.11

94.50

2.5

2.1

31.9

32.8

6.74

948

3290

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

427

998

3.11

93.35

2.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

859

2856

2.19

92.95

1.3

1.2

u/l

72.7

65.9

0.44

629

1862

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

392

871

3.27

92.95

2.6

2.0

ug/l

61.9

63.9

0.17

387

848

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

235

355

4.80

92.94

1.4

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

465

1156

2.93

91.58

1.8

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

465

1157

2.92

91.44

1.8

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

744

2346

2.31

91.23

1.8

1.4

promille

1.4

0.20

560

1803

(3047007) Chlamydophila sp Ab [Presence] in Serum

1139

4249

1.96

90.90

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

794

2595

2.23

89.56

1.6

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

363

788

3.35

89.26

6.5

5.7

mmol/l

24.9

25.1

0.37

329

726

(3021788) Differential panel - Synovial fluid

1288

5050

1.86

88.60

1.6

1.5

—

(3014271) Vancomycin [Susceptibility]

450

1123

2.91

88.05

3.2

2.7

—

(21494434) Karyotype in Bone marrow

688

2131

2.35

87.85

1.2

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1303

5151

1.85

87.35

4.9

2.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

371

831

3.24

86.90

1.3

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1586

6666

1.74

86.76

1.7

1.6

e6/l

16631.6

12421.6

2.13

1184

4823

(3052592) Norovirus Ag [Presence] in Stool

233

373

4.53

86.24

1.5

1.2

—

(3016038) Potassium [Moles/volume] in Urine

571

1639

2.54

85.77

1.3

mmol/l

30.9

35.3

4.53

480

1424

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

41811

315962

0.80

85.40

5.0

4.7

mmol/l

2.6

2.8

297.57

38412

293262

(3017732) Neutrophils [#/volume] in Blood

3995

20838

1.42

84.32

3.8

2.5

e9/l

4.6

4.0

29.22

3037

16336

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

15134

94373

1.22

84.09

4.5

4.7

ug/l

3.4

3.0

0.83

13442

85345

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

827

2820

2.14

84.07

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1993

9007

1.62

83.02

2.1

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2122

9751

1.60

82.56

1.5

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

431

1093

2.87

82.01

7.4

4.6

mg/l

1263.3

2482.1

0.69

337

769

(3051611) Lipemic interference index of Serum or Plasma

823

2837

2.11

81.39

4.7

3.1

—

(40762365) Oxygen content in Arterial blood by calculation

219

350

4.54

81.25

3.0

ml/dl

14.8

0.02

204

325

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

165

202

5.92

81.15

1.3

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

242

421

4.17

80.98

6.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

600

1820

2.40

80.26

1.3

1.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

154

183

6.10

77.91

4.4

mg/l

2.1

2.3

0.48

132

159

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

161

201

5.81

77.73

1.3

u/l

339.7

202.3

0.22

117

153

(3016650) Hepatitis A virus Ab [Presence] in Serum

1215

4876

1.82

77.61

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

31614

211974

1.19

77.61

4.1

2.9

u/l

60.9

45.3

108.75

29634

198688

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1212

4865

1.82

77.36

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

115

8.59

76.98

1.6

1.4

—

(3044889) 12 lead EKG panel

31667

212472

1.19

76.60

4.7

3.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

208

336

4.49

76.24

1.2

1.5

ng/l

116.7

358.9

0.41

143

193

(3041096) Erythrocytes [Presence] in Urine by Automated

13270

82317

1.22

75.92

4.4

3.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

1837

8318

1.62

75.85

1.2

1.3

titre

111.3

124.4

0.37

174

747

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

178

252

5.12

75.66

1.5

u/ml

63.6

61.6

—

(3034770) Mitochondria Ab [Titer] in Serum

1808

8164

1.62

75.49

1.2

titre

875.1

957.5

0.20

234

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

140

157

6.46

74.67

1.3

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

1368

5754

1.74

74.58

4.8

2.7

mmol/l

1.6

0.72

1335

5639

(3041354) Potassium [Moles/volume] in Venous blood

853

3082

2.02

74.49

3.3

2.0

mmol/l

4.1

4.0

0.37

844

3063

(3035285) Chloride [Moles/volume] in Venous blood

852

3081

2.02

74.23

3.3

2.0

mmol/l

104.9

105.8

6.10

843

3061

(3013005) Retinol [Moles/volume] in Serum or Plasma

437

1184

2.68

73.64

2.1

1.9

umol/l

1.9

0.00

413

1117

(3004451) EKG impression Narrative

427

1143

2.71

73.63

1.4

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1067

4180

1.86

73.57

1.3

u/l

57.1

27.3

6.58

929

3654

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

182

271

4.87

73.25

1.4

13.8

11.8

0.38

138

(3014765) Yersinia sp identified in Stool by Organism specific culture

1858

8526

1.60

72.59

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1861

8548

1.59

72.42

1.3

1.1

—

(3047189) Immunofixation for 24 hour Urine

395

1027

2.79

71.92

2.1

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1842

8455

1.60

71.88

1.3

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2394

11667

1.51

71.50

1.3

1.2

u/ml

0.8

0.06

184

997

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

524

1577

2.42

71.35

1.3

1.2

u/l

115.2

83.6

5.55

476

1363

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2062

9767

1.55

70.23

3.4

3.5

u/ml

1075.3

2094.2

0.69

1751

8393

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

159

218

5.29

69.94

3.3

2.5

mg/l

1.2

1.4

0.45

107

150

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6904

40151

1.28

69.48

2.1

1.7

1.6

1.4

51.17

5976

35664

(3041918) Cholesterol [Moles/volume] in Pleural fluid

201

341

4.27

69.48

1.2

mmol/l

1.6

1.8

0.55

139

189

(3033705) Calcium.ionized [Moles/volume] in Venous blood

827

3038

1.98

68.99

3.4

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1556

17690

0.63

68.93

1.7

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1631

7343

1.63

68.87

1.4

mg/l

591.1

531.6

1.20

1544

7020

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

508

1534

2.41

68.69

1.3

1.2

u/l

37.7

20.0

6.47

453

1304

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

714

2531

2.05

65.70

1.3

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

992

3955

1.83

64.74

1.1

g/l

1.6

1.5

8.00

907

3571

(3032057) Clostridioides difficile [Presence] in Stool

227

447

3.68

64.55

2.0

1.7

—

(4198724)

475

1433

2.41

64.40

2.4

2.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

142

192

5.36

63.41

1.5

1.3

64.8

76.4

3.05

120

169

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

277

634

3.17

62.85

2.0

u/l

47.8

34.9

0.58

254

566

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1445

6483

1.63

61.84

1.4

1.3

mmol/l

3.9

3.7

7.12

1347

6112

(3019150) Specific gravity of Urine by Refractometry

10614

65510

1.21

61.49

5.2

3.7

kg/l

1.0

0.55

1660

9811

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1350

5965

1.65

61.35

1.2

u/ml

8.8

17.2

0.64

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

680

2437

2.03

60.79

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1075

4481

1.75

60.49

1.3

1.2

u/ml

4.5

3.9

0.86

508

1984

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

39531

298234

0.84

60.39

4.2

3.8

mmol/l

1.4

1.3

108.81

36100

275664

(3042010) Triglyceride [Moles/volume] in Pleural fluid

165

268

4.46

60.20

1.3

1.2

mmol/l

0.7

2.1

2.24

109

169

(3038515) Glucose [Moles/volume] in Venous blood

1248

5439

1.67

59.78

5.1

2.7

mmol/l

7.9

7.5

3.24

1221

5342

(3044941) Cell count panel - Synovial fluid

1030

4257

1.76

59.68

1.5

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

514

1666

2.24

59.29

1.7

1.5

u/l

7.1

6.0

0.57

288

766

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

31037

209916

1.16

59.23

3.4

3.0

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

527

1727

2.22

59.22

13.7

11.8

mmol/l

0.7

0.6

2.68

480

1593

(3044290) Cell count panel - Cerebral spinal fluid

1362

6103

1.63

58.58

1.5

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

427

1282

2.42

58.55

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1109

4709

1.72

58.46

1.1

au/ml

13.9

12.2

0.17

325

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1271

5612

1.65

57.92

3.3

3.4

u/ml

530.4

854.7

0.85

1146

5102

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

842

3305

1.86

57.76

1.2

1.1

iu/ml

2.6

1.8

0.66

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

374

1061

2.56

57.72

2.5

2.4

—

(3048879) Bone marrow aspiration report

275

667

2.99

56.74

2.2

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

537

1812

2.15

56.20

2.2

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1418

6486

1.60

56.08

1.6

1.5

e6/l

1474.0

2383.6

0.55

1180

5234

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1412

15667

0.64

55.71

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1414

6483

1.59

55.37

1.6

1.4

e6/l

33.1

29.9

0.14

1117

4974

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1083

4642

1.70

55.19

1.3

1.2

u/ml

4.6

3.5

0.76

375

1601

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

614

2199

2.03

55.04

1.3

mmol/l

2.2

2.0

3.15

569

2046

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

866

3487

1.81

54.78

1.7

1.5

60.5

55.5

3.17

570

2195

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

517

1745

2.15

54.09

2.5

2.3

97.1

97.2

0.02

500

1625

(3028707) Methadone [Presence] in Urine by Screen method

1272

5717

1.62

54.05

4.3

2.8

—

(3000963) Hemoglobin [Mass/volume] in Blood

48026

354914

0.79

53.79

38.9

17.2

g/l

131.3

136.9

307.65

47445

350095

(3023420) DNA double strand Ab [Units/volume] in Serum

786

3094

1.85

53.47

1.8

1.5

iu/ml

33.5

29.5

0.24

129

(3026361) Erythrocytes [#/volume] in Blood

48022

354803

0.79

52.52

38.6

17.1

e12/l

4.4

4.5

307.65

46959

344363

(3024731) MCV [Entitic volume]

48018

354767

0.79

52.37

38.4

17.0

91.1

90.7

74.23

47442

349878

(3010813) Leukocytes [#/volume] in Blood

48034

354866

0.79

52.29

38.7

17.1

e9/l

7.4

6.6

307.65

46964

344438

(3049717) Cytology report of Urine Cyto stain

2063

10384

1.45

52.20

2.5

2.7

—

(3035941) MCH [Entitic mass]

48018

354727

0.79

51.78

38.4

17.0

30.2

30.3

14.93

47438

349853

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

339

968

2.54

51.70

2.5

2.4

nmol/l

148.0

150.6

0.17

293

830

(3029634) Reagin Ab [Titer] in Serum by VDRL

1015

4365

1.69

51.12

2.3

2.1

titre

8.0

7.1

0.07

138

(3011544) Albumin [Mass/volume] in Pleural fluid

119

169

5.10

50.57

1.1

1.2

g/l

17.2

18.0

0.42

112

145

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

460

1531

2.18

49.87

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

451

1492

2.20

49.63

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

328

947

2.51

48.94

3.1

2.9

umol/l

29.5

28.4

0.86

234

740

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1307

6061

1.57

48.77

1.3

1.2

u/ml

4.7

5.3

0.12

116

435

(3007461) Platelets [#/volume] in Blood

48008

354441

0.80

48.60

38.6

17.1

e9/l

255.1

251.9

17.85

47070

344982

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

461

1555

2.15

48.37

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

412

1334

2.24

47.76

1.8

1.5

iu/ml

1844245.9

1931988.6

0.04

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

543

1965

2.01

47.39

1.4

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4183

23898

1.29

47.22

3.5

2.5

ml/min/173m2

60.0

68.5

26.06

1868

9074

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

113

6.02

47.20

1.1

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1442

6921

1.52

46.13

2.7

2.3

ug/min

139.7

103.6

2.00

887

4104

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1657

8189

1.48

46.02

1.3

u/ml

34.4

36.7

0.15

118

472

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

776

3193

1.77

45.74

1.2

1.1

93.4

96.8

2.61

735

2983

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

954

4160

1.67

45.66

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1547

7555

1.49

45.56

1.3

u/ml

7.5

8.5

0.27

274

1127

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1525

7449

1.49

44.87

1.3

u/ml

7.2

5.8

0.31

191

729

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1454

7049

1.51

44.36

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

149

286

3.77

44.07

4.0

2.6

umol/l

38.6

42.6

1.21

129

245

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

195

450

3.14

43.85

2.6

2.5

mg/l

75.7

38.0

1.18

(40758047) Lysozyme [Mass/volume] in Pleural fluid

108

161

4.86

43.60

1.2

1.1

mg/l

10.6

8.4

0.93

103

146

(3012565) Volume of 24 hour Urine

412

1390

2.15

43.28

2.4

2.1

1866.9

2021.8

1.70

358

1244

(4306422)

1010

4532

1.62

43.25

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

896

10395

0.62

43.03

1.5

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

981

4383

1.63

42.74

1.2

1.1

116.7

118.5

0.82

914

3945

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3407

19239

1.30

41.87

3.2

3.4

pmol/l

4.3

4.5

23.43

2990

17211

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

117

194

4.37

41.79

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

220

564

2.83

41.36

1.4

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

118

200

4.27

41.05

1.1

u/l

18.7

20.9

0.57

128

(43055442) Apixaban [Mass/volume] in Serum or Plasma

140

271

3.74

40.97

1.5

ug/l

112.6

115.0

0.08

114

215

(40757494) Bilirubin.total [Moles/volume] in Blood

420

1460

2.09

40.91

2.3

2.2

umol/l

42.6

48.2

0.21

145

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

921

10458

0.63

40.24

1.4

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

931

4192

1.62

39.35

1.5

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

122

5.28

39.34

5.5

4.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

107

176

4.40

38.63

1.0

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

8425

52829

1.18

38.44

1.3

iu/ml

42.0

35.2

2.02

2648

16355

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

421

1503

2.03

38.25

1.7

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

197

497

2.87

38.16

1.3

1.2

—

(3000012) Reticulocyte production index

408

1441

2.06

38.16

1.6

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

885

3969

1.62

38.03

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

154

337

3.31

37.74

3.4

2.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1360

6734

1.47

37.43

1.3

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

903

4087

1.61

37.39

2.7

2.9

u/ml

281.0

868.8

1.18

873

3908

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

165

380

3.15

37.31

5.6

4.9

ug/min

47.8

44.6

0.25

138

287

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

176

424

3.01

36.95

3.4

2.2

mmol/l

1.2

0.73

166

404

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

644

2677

1.75

36.76

1.6

1.5

25.0

32.7

6.39

401

1673

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

984

4571

1.57

36.52

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

232

655

2.57

36.39

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

329

1091

2.19

36.17

1.1

1.2

—

(3033799) Differential panel - Peritoneal fluid

258

770

2.43

36.08

2.1

1.8

—

(3022621) pH of Urine by Test strip

3348

19235

1.28

35.81

3.5

2.7

—

(4268621)

711

3072

1.68

35.34

2.4

2.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

104

181

4.16

35.08

2.5

3.2

—

(3016750) Collection duration of Urine

434

1617

1.95

35.05

2.4

2.1

min

496.2

500.7

0.37

307

1223

(3034988) Calcium [Moles/volume] in Capillary blood

181

458

2.86

34.93

3.6

2.3

mmol/l

1.2

0.24

171

440

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

647

7717

0.60

34.91

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

335

1141

2.13

34.49

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

790

3534

1.63

34.34

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

213

594

2.60

34.27

1.1

1.2

titre

142.9

641.3

—

(3020393) Adenovirus Ag [Presence] in Stool

149

342

3.16

33.93

1.7

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

608

2545

1.74

33.92

1.4

1.3

nmol/l

1.5

1.4

0.97

554

2291

(3026692) Albumin [Mass/volume] in Peritoneal fluid

217

618

2.55

33.50

1.3

1.4

g/l

14.5

12.9

1.75

168

465

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

506

2019

1.82

33.18

2.1

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

280

904

2.25

32.88

2.3

1.9

e6/l

3494.4

3659.2

0.02

194

611

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

585

7043

0.60

32.80

1.8

—

(40768795) Lymph node Pathology biopsy report

639

2742

1.69

32.62

1.3

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1187

5885

1.47

32.49

1.5

1.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.37

32.46

1.7

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

429

1636

1.90

32.40

1.6

1.4

u/l

6.4

5.8

0.42

351

1390

(40768804) Tissue Pathology biopsy report

18635

124764

1.12

32.08

2.2

2.0

—

(3003129) Base excess in Capillary blood by calculation

221

649

2.47

32.05

2.0

1.6

mmol/l

1.4

0.3

3.56

210

611

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

162

406

2.89

31.85

1.4

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

808

3703

1.59

31.84

2.0

1.8

titre

2482.1

4330.6

0.96

166

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

469

1852

1.84

31.82

1.6

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

125

269

3.37

31.52

8.4

6.9

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

478

1910

1.82

31.24

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

469

1864

1.83

31.19

1.7

1.5

u/ml

31.9

22.1

2.28

367

(3008116) Ketones [Moles/volume] in Urine by Test strip

184

501

2.66

31.08

1.7

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

11566

75314

1.14

30.91

3.9

4.1

21.9

0.16

5144

35048

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

768

3503

1.59

30.89

2.7

1.9

mg/l

29.0

25.6

0.90

254

894

(3025315) Body weight

102

194

3.81

30.71

5.7

3.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

478

1921

1.81

30.67

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

606

2610

1.69

30.56

1.5

1.4

e6/l

128685.2

103427.9

0.38

415

1805

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

211

622

2.46

30.39

10.8

7.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

160

4.12

30.36

8.0

3.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

379

1421

1.94

30.14

1.2

1.1

u/l

91.1

84.7

0.72

300

1128

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

379

1421

1.94

30.14

1.2

1.1

u/l

30.9

23.5

1.41

287

1094

(3006922) Hepatitis E virus Ab [Presence] in Serum

509

2096

1.76

30.12

1.1

—

(40765096) Chromosome analysis panel by Banding

232

719

2.34

29.99

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

250

802

2.26

29.86

2.1

1.8

e6/l

9168.8

12622.2

0.35

133

429

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

464

5780

0.58

29.76

1.5

1.4

—

(3004775) Volume in Urine collected for unspecified duration

531

2223

1.73

29.68

2.5

2.2

709.8

674.2

0.97

358

1532

(3034426) Prothrombin time (PT)

285

968

2.13

29.64

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

208

617

2.44

29.58

1.2

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

416

1621

1.86

29.48

1.2

1.3

titre

201.8

491.6

1.69

105

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

407

1580

1.87

29.18

1.2

1.3

titre

84.4

77.2

0.14

141

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

736

8178

0.65

29.13

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

257

845

2.20

28.98

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

535

2261

1.72

28.94

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

739

8192

0.65

28.93

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

333

1211

1.99

28.92

2.6

2.4

umol/l

58.6

53.1

2.28

266

1016

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

531

2240

1.72

28.91

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

739

8187

0.65

28.85

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

530

2239

1.72

28.71

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

529

2235

1.72

28.65

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

735

8140

0.65

28.65

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

399

1549

1.87

28.62

1.9

1.7

u/field

2.5

2.4

0.06

294

1112

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

532

2258

1.71

28.35

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

505

2113

1.73

28.31

1.3

1.2

u/ml

11.1

8.9

0.14

149

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7817

49789

1.16

28.30

1.3

u/ml

16.6

10.8

5.47

2745

19739

(3016018) Differential panel - Cerebral spinal fluid

710

3247

1.59

28.29

1.6

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

532

2260

1.71

28.26

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

212

649

2.37

28.20

1.2

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

523

2218

1.71

27.96

1.3

1.2

u/ml

35.5

50.9

0.96

158

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

521

2215

1.71

27.61

1.3

1.2

u/ml

81.8

65.5

0.52

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1054

10791

0.70

27.26

1.5

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

530

2274

1.69

27.17

1.3

1.2

u/ml

40.3

55.5

0.51

(3044416) Complement C4 [Mass/volume] in Pleural fluid

5.36

27.05

1.1

1.2

g/l

0.1

0.48

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

811

8695

0.67

26.95

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

186

554

2.43

26.30

1.5

1.3

g/l

34.3

25.9

0.57

145

431

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

172

3.75

26.29

3.9

2.1

—

(3003338) MCHC [Mass/volume]

36649

273714

0.90

26.18

33.7

14.7

g/l

330.9

333.1

307.65

36290

271727

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

327

1225

1.94

26.16

2.4

1.9

umol/l

27.3

29.1

2.02

315

1189

(3022145) Colonoscopy Study observation

5535

34513

1.18

26.12

1.4

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

222

718

2.24

26.10

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.31

25.92

1.8

1.1

—

(3002256) Pathology report gross observation

6290

39696

1.17

25.49

1.3

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

5.79

25.30

1.1

g/l

0.2

0.10

(3027923) C peptide [Moles/volume] in Serum or Plasma

378

1502

1.83

25.28

1.4

1.6

nmol/l

1.3

1.2

0.70

276

1184

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

217

709

2.22

24.93

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

177

529

2.42

24.88

1.4

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

177

530

2.42

24.78

1.4

1.1

—

(3000330) Specific gravity of Urine by Test strip

2470

14293

1.26

24.75

4.3

3.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

216

709

2.21

24.55

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

113

268

3.05

24.55

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

176

529

2.41

24.45

1.4

1.1

—

(3045414) Leukocytes [Presence] in Urine

2336

13451

1.27

24.40

2.1

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

512

2242

1.66

24.38

2.1

1.9

u/field

2.0

2.4

1.02

253

965

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

103

4.50

23.87

4.0

—

(3044007) Cell count panel - Peritoneal fluid

217

725

2.17

23.65

2.3

1.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

107

4.40

23.60

4.1

4.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

199

642

2.25

23.59

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

199

642

2.25

23.59

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

199

642

2.25

23.59

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

199

642

2.25

23.59

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

310

1183

1.90

23.55

8.4

9.9

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

433

1830

1.72

23.54

2.9

2.8

ug/l

27.7

26.1

—

(3024263) Appearance of Synovial fluid

360

1442

1.81

23.50

1.7

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2593

15182

1.25

23.45

2.5

2.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

346

1371

1.83

23.40

1.6

1.4

2.9

4.7

1.79

292

(21491868) Cryoglobulin [Mass/volume] in Serum

264

955

2.00

23.39

1.3

1.2

g/l

0.5

0.6

0.06

(3020717) Zinc [Moles/volume] in Serum or Plasma

365

1471

1.80

23.36

1.9

1.5

umol/l

18.9

26.1

5.63

349

1401

(3039162) Centromere protein B Ab [Units/volume] in Serum

760

3690

1.50

23.22

1.3

1.2

u/ml

57.0

51.2

0.24

227

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

34477

240627

1.10

22.94

4.3

3.9

pmol/l

14.8

14.7

15.52

31490

219595

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1166

6143

1.38

22.89

1.3

1.2

u/ml

39.2

42.6

0.34

142

571

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

166

3.58

22.76

1.5

2.1

ug/g

185.9

175.3

0.23

143

(3005033) Fetal Nuchal fold Thickness US

604

6635

0.65

22.72

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

1321

7114

1.35

22.59

5.2

3.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

140

3.83

22.56

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

179

563

2.30

22.54

11.0

7.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

606

6640

0.66

22.51

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

245

875

2.03

22.51

1.3

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

625

6804

0.66

22.49

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

211

713

2.14

22.39

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1149

6070

1.38

22.20

3.0

1.9

nmol/l

1.0

0.8

6.82

947

5116

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

328

1303

1.83

22.04

2.3

2.2

ug/l

22.7

234.8

1.80

316

1234

(3009214) Lutropin [Units/volume] in Serum or Plasma

1733

9736

1.30

22.03

1.5

1.4

u/l

10.0

9.6

0.57

1366

7943

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

199

662

2.18

21.96

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

172

538

2.32

21.94

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

124

3.97

21.77

4.3

3.0

—

(3009871) Measles virus Ab [Titer] in Serum

268

1002

1.94

21.68

1.6

1.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

115

4.09

21.64

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

641

3055

1.52

21.43

1.8

1.7

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

6.08

21.42

6.2

4.6

mg/l

7.7

5.0

0.47

(3017315) Amylase [Enzymatic activity/volume] in Urine

373

1554

1.74

21.39

1.2

1.3

u/l

287.7

334.3

0.39

345

1453

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

112

287

2.83

21.36

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1283

12244

0.75

21.20

1.9

1.6

mg/l

6.1

3.2

7.91

1031

8438

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

112

289

2.81

21.10

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

111

285

2.82

21.10

1.3

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

675

3265

1.50

21.06

1.4

1.3

nmol/l

20.4

34.5

—

(3011985) Renin [Units/volume] in Plasma

812

4076

1.45

21.01

1.6

1.5

mu/l

66.7

64.9

0.09

714

3656

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

5.18

20.97

1.1

1.2

ng/l

3957.1

2727.2

0.33

(3002385) Erythrocyte distribution width [Ratio]

37616

264093

1.10

20.80

31.7

14.0

14.1

13.6

307.65

37010

258442

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

476

2134

1.62

20.75

1.4

umol/l

13.9

11.8

6.86

443

2035

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

128

358

2.59

20.72

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4870

40365

0.86

20.70

2.2

2.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

269

2.85

20.59

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

5.66

20.51

10.8

6.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.79

20.50

1.1

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

657

3180

1.50

20.45

1.1

au/ml

26.8

22.8

—

(40768441) Liver Pathology biopsy report

479

2163

1.61

20.29

1.4

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

118

3.93

20.23

10.4

9.2

e6/l

311.0

280.0

0.06

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

336

1385

1.76

20.03

1.9

166.1

136.8

7.27

316

1308

(3048689) Calprotectin [Mass/mass] in Stool

6137

39304

1.15

19.98

2.5

2.4

ug/g

169.0

128.9

8.48

4977

30851

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

186

627

2.15

19.93

1.6

1.5

ug/l

0.4

0.35

127

408

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2565

22383

0.82

19.82

2.1

2.0

—

(3045424) Erythrocytes [Presence] in Urine

973

5101

1.39

19.75

1.6

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

639

3102

1.50

19.63

1.1

au/ml

58.4

65.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

161

3.37

19.18

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

450

2031

1.61

19.14

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

335

1400

1.73

19.07

1.4

1.2

61.3

64.4

0.23

137

(40758292) HTLV I+II Ab panel - Serum

148

463

2.31

18.96

1.6

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

167

3.29

18.76

2.3

2.2

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

4.32

18.60

5.9

5.7

mmol/l

16.3

17.7

0.82

(3011288) Drugs identified in Urine by Screen method

1622

9241

1.28

18.53

5.3

2.9

—

(3002619) Bacteria identified in Specimen by Culture

170

570

2.16

18.50

1.3

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

320

1333

1.74

18.45

2.2

2.1

ug/min

107.7

101.2

0.08

285

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

139

429

2.35

18.37

1.2

1.1

pmol/l

4.4

7.2

0.30

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

177

605

2.12

18.36

1.2

90.6

87.6

0.30

148

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

176

601

2.12

18.30

1.1

1.2

78.5

74.3

0.42

142

(3006442) Creatine [Moles/volume] in Serum or Plasma

452

2066

1.59

18.27

1.8

1.4

umol/l

66.6

70.7

0.58

165

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

287

1162

1.79

18.24

1.1

—

(40768443) Skin Pathology biopsy report

2231

13212

1.23

18.18

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

127

378

2.43

18.17

1.3

1.5

nmol/l

7.1

272850.7

2.38

313

(3002523) Influenza virus A Ag [Presence] in Specimen

954

5062

1.37

18.03

1.2

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

5.06

17.95

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

664

3309

1.46

17.94

3.4

3.2

nmol/l

7.5

7.1

0.07

642

3208

(3003740) Influenza virus B Ag [Presence] in Specimen

953

5065

1.37

17.83

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

109

304

2.60

17.82

1.3

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

459

2119

1.57

17.80

3.2

2.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

124

369

2.43

17.76

1.2

1.1

—

(3012898) Urea [Moles/volume] in Urine

100

268

2.70

17.65

1.4

1.6

mmol/l

158.4

175.1

0.58

239

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

473

2206

1.56

17.55

1.3

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

495

2333

1.54

17.53

1.2

1.1

u/ml

90.6

57.8

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

142

3.41

17.50

1.1

u/field

1.2

1.3

0.28

(3051387) C reactive protein [Mass/volume] in Capillary blood

1151

6318

1.32

17.41

4.8

3.0

mg/l

32.5

24.8

9.01

824

3848

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4433

36540

0.87

17.29

2.1

2.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.27

17.29

1.3

1.1

—

(3042517) Benzodiazepines panel - Urine

125

379

2.39

17.21

2.7

3.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

126

384

2.38

17.16

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

345

1501

1.67

17.03

6.3

5.9

u/ml

147.5

3861.7

1.03

296

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4372

36032

0.87

17.00

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

268

1089

1.78

16.87

3.0

2.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2031

17828

0.82

16.64

2.0

1.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

547

2666

1.49

16.58

4.5

3.6

u/ml

62.0

46.7

0.89

542

2632

(3036670) Protein [Mass/volume] in Synovial fluid

212

806

1.91

16.48

1.2

g/l

38.4

40.6

1.33

125

425

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

175

622

2.04

16.45

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

113

336

2.43

16.26

10.8

9.3

umol/l

0.4

0.37

103

306

(3036603) Volume of Urine

419

1937

1.57

16.21

1.9

1.6

1789.2

1973.0

1.04

102

418

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

177

638

2.01

16.04

1.2

1.3

108.8

106.3

0.37

169

605

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

156

537

2.10

15.97

4.5

6.6

67.1

71.7

1.18

111

444

(3039443) Prostate specific Ag panel - Serum or Plasma

606

6199

0.70

15.76

1.5

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

41536

294100

1.10

15.65

23.7

10.8

ml/min/173m2

81.1

83.7

83.45

35944

240144

(3043410) Blood group antigens tested for on Red Blood Cells

197

745

1.92

15.59

2.1

1.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

250

1020

1.78

15.58

1.9

2.0

197.3

157.9

5.57

240

964

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

128

411

2.25

15.55

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.90

15.44

4.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.49

15.40

1.1

mmol/l

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

118

368

2.32

15.33

2.3

2.4

mmol/l

1.4

0.07

270

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

221

874

1.83

15.26

1.3

1.2

29.5

18.8

1.19

133

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

5.01

15.24

11.9

6.2

40.4

44.9

0.34

(3000034) Microalbumin [Mass/volume] in Urine

524

2577

1.47

15.24

3.1

3.0

mg/l

93.1

44.9

2.00

399

1829

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

235

948

1.80

15.22

1.1

85.1

91.4

1.24

127

438

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.52

15.13

7.0

5.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

178

657

1.96

15.13

1.1

—

(3005570) Glucose [Moles/volume] in Urine

570

2864

1.44

14.85

2.2

1.8

mmol/l

12.0

25.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10539

70686

1.10

14.78

1.3

u/ml

1.7

0.19

2709

19301

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4115

33740

0.87

14.78

1.5

1.4

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

6.14

14.46

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

723

3808

1.38

14.42

1.3

1.4

pmol/l

300.7

302.1

0.02

550

2975

(1001926) Buprenorphine [Presence] in Urine by Screen method

1805

10718

1.23

14.39

3.7

2.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.69

14.39

1.9

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

134

454

2.14

14.34

1.4

1.3

titre

102.7

181.2

0.43

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

237

979

1.75

14.21

1.1

85.7

91.0

1.40

128

448

(46236302) HLA-C [Type] by High resolution typing

3.83

14.17

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

240

998

1.74

14.07

1.2

101.4

107.8

1.41

225

900

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

120

392

2.22

14.05

1.1

—

(3007463) Buprenorphine [Presence] in Urine

120

3.32

13.84

8.9

6.9

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

148

530

2.02

13.73

2.6

2.5

mmol/l

8.0

7.3

1.00

314

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

190

2.78

13.71

1.2

ug/l

96.7

111.7

0.44

119

(3032352) Blasts [#/volume] in Cerebral spinal fluid

284

2.42

13.60

2.1

2.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

119

393

2.19

13.59

1.5

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

415

1995

1.51

13.55

1.1

iu/ml

9.1

8.3

0.25

505

(40760409) HLA-A [Type] by High resolution

3.74

13.47

1.0

—

(40760410) HLA-B [Type] by High resolution

3.74

13.47

1.0

—

(40763590) HLA-DQ beta [Type]

3.74

13.47

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3889

24781

1.15

13.44

2.4

2.2

nmol/l

12.0

12.8

6.41

3377

22169

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

213

2.65

13.41

2.3

2.2

61.3

57.7

0.31

131

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

247

2.52

13.39

1.0

1.1

—

(3013862) HLA-DP [Type]

3.70

13.27

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

279

2.41

13.23

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

449

2208

1.47

13.15

2.2

1.7

mmol/l

7.4

6.6

3.77

329

1597

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

338

3720

0.65

13.06

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

423

2058

1.49

13.06

3.2

3.1

mu/l

25.2

27.6

0.55

394

1931

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

220

914

1.74

12.99

1.4

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

109

354

2.23

12.98

1.4

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

269

2.42

12.91

2.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

214

2.60

12.82

1.3

pmol/l

15.8

12.6

0.43

181

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

3.85

12.78

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

550

2827

1.41

12.73

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

1158

6639

1.27

12.70

2.5

2.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

147

550

1.94

12.13

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

422

4350

0.70

11.62

1.4

1.3

ug/l

3.3

3.8

0.64

362

3864

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

710

3864

1.33

11.58

1.4

1.3

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.62

11.48

1.1

1.0

mmol/l

5.7

5.0

0.54

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

771

4258

1.31

11.35

1.3

nmol/l

0.3

0.2

0.11

256

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

772

4265

1.31

11.34

1.3

nmol/l

0.6

1.3

1.07

720

4131

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

111

386

2.08

11.24

1.5

1.1

mmol/l

21.1

20.3

1.17

334

(4212803)

216

2.48

11.22

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1778

10807

1.20

11.21

1.7

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

3.83

11.17

5.7

mg/l

1.2

1.5

0.36

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

234

2.41

11.17

1.2

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

134

2.92

11.12

21.6

9.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2550

15983

1.16

11.10

1.4

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

5.89

10.98

1.6

1.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

197

2.53

10.96

1.1

iu/ml

18.0

16.8

0.05

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

169

685

1.79

10.94

1.2

pmol/l

399.5

315.1

0.40

121

510

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

241

2.37

10.93

1.3

1.4

ml/s/173m2

0.9

1.7

1.83

156

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

302

1425

1.54

10.88

1.1

1.2

u/ml

10.1

12.2

0.16

133

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

520

2730

1.38

10.73

2.1

2.3

nmol/l

18.1

19.4

1.60

481

2598

(3010015) Selenium [Moles/volume] in Serum or Plasma

257

2.31

10.69

2.4

2.1

umol/l

1.2

1.3

1.75

230

(3004446) Plasmodium sp identified in Blood by Light microscopy

290

2.22

10.61

2.7

2.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

141

548

1.86

10.47

1.3

1.2

mg/l

91.7

35.0

0.51

402

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

297

2.19

10.42

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

390

1960

1.44

10.33

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

175

740

1.71

9.85

1.5

1.3

umol/l

17.7

16.8

1.26

154

660

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

315

2.11

9.76

2.1

2.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

236

2.30

9.74

1.1

1.0

—

(4094501)

958

8583

0.80

9.69

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

106

3.00

9.58

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

293

1417

1.50

9.48

1.5

1.6

mmol/24h

5.8

5.6

0.06

114

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

8145

54968

1.08

9.44

2.8

2.9

ug/l

0.8

0.05

5440

34897

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

40410

287320

1.07

9.40

5.2

4.6

mu/l

2.2

2.1

0.56

37207

264769

(3022229) Phosphate [Moles/volume] in Urine

195

2.41

9.38

1.8

2.6

mmol/l

17.6

20.1

0.52

170

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

107

394

1.97

9.37

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

132

2.74

9.29

1.2

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

4.57

9.27

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

189

2174

0.63

9.14

1.4

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

161

682

1.71

9.05

1.4

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

103

380

1.96

8.99

1.7

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

253

1203

1.52

8.90

1.1

ng/l

761.3

544.1

0.28

268

(3029075) Extractable nuclear Ab panel - Serum

196

879

1.61

8.88

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2040

12805

1.16

8.78

1.1

u/ml

19.6

7.9

0.45

189

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

787

4515

1.26

8.75

4.2

3.4

u/ml

43.4

36.2

0.60

765

4345

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

283

1383

1.48

8.75

1.1

miu/ml

1505.0

1524.1

0.11

283

1383

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

6.43

8.62

1.1

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

147

617

1.72

8.57

1.3

mu/l

132.3

65.1

0.72

111

461

(3039744) RNA polymerase III Ab [Units/volume] in Serum

229

2.21

8.37

1.1

1.0

u/ml

8.7

2.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

107

411

1.88

8.34

6.3

7.2

—

(3018133) Calcium [Moles/volume] in Urine

133

548

1.76

8.28

2.1

2.3

mmol/l

2.4

2.7

1.02

118

497

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.19

8.22

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

365

1894

1.40

8.21

1.2

1.1

ratio

1.1

1.08

122

677

(4024509)

492

2680

1.33

8.15

1.6

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.03

8.00

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

183

2.33

7.99

1.4

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

41032

300898

0.94

7.89

4.9

4.3

mmol/l

6.1

5.9

155.89

37396

276634

(3018738) Hemoglobin F/Hemoglobin.total in Blood

217

2.20

7.83

5.6

2.7

17.2

9.7

1.67

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

230

2451

0.68

7.79

1.5

1.6

mmol/l

8.0

7.7

1.04

150

1444

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1233

7506

1.19

7.78

1.7

1.9

iu/l

65.0

12.4

0.49

380

2813

(3009992) Blasts/100 cells in Bone marrow

7.23

7.69

2.0

1.6

13.6

26.2

0.58

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

173

2.34

7.67

2.3

2.1

12.7

18.0

0.60

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

394

2097

1.36

7.64

1.4

1.2

—

(3006270) Folate [Moles/volume] in Blood

444

2407

1.34

7.63

1.2

1.1

nmol/l

338.3

372.7

2.37

363

2055

(3035933) Granulocytes/100 leukocytes in Blood

191

885

1.56

7.63

2.1

1.6

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

101

393

1.86

7.61

1.2

1.4

45.2

55.1

1.11

197

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

391

2083

1.36

7.54

1.4

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

220

1055

1.51

7.53

1.3

1.4

pmol/l

16.7

14.6

1.47

188

878

(3013166) Neutrophils/100 leukocytes in Synovial fluid

187

866

1.56

7.50

1.4

62.1

53.5

2.43

157

745

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

434

2353

1.34

7.47

1.1

mg/l

299.8

413.5

0.43

395

2107

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

167

756

1.60

7.38

1.4

1.3

nmol/l

133.2

122.6

0.34

116

563

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1835

11589

1.15

7.32

1.7

1.6

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.82

7.30

1.1

u/field

1.0

1.4

0.55

(3019174) dRVVT (LA screen)

253

2.06

7.27

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

384

1.85

7.25

1.1

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

4.65

7.12

1.2

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

132

2.47

6.92

1.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

150

2.36

6.88

1.2

1.4

u/l

1765.5

831.5

0.28

131

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

126

542

1.68

6.83

1.5

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

143

1632

0.63

6.83

1.3

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.79

6.82

1.3

1.4

u/field

0.7

0.03

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

588

3366

1.27

6.79

1.1

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

129

2.47

6.78

1.0

1.1

21.0

21.5

0.34

118

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

129

2.47

6.78

1.0

8.9

8.8

0.12

119

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

129

2.47

6.78

1.0

1.1

36.7

36.1

0.33

120

(3025549) Creatine [Moles/time] in 24 hour Urine

226

2.08

6.77

1.5

1.4

—

11.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

831

4945

1.22

6.74

1.1

iu/ml

55.0

2940.1

0.80

179

1097

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

203

982

1.50

6.73

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

342

1.86

6.72

5.5

5.6

g/mol

41.7

225.4

0.71

314

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

155

707

1.59

6.69

1.5

1.2

36.4

40.6

0.69

105

465

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1008

6120

1.19

6.63

1.7

1.6

—

(44806071)

396

1.79

6.62

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

119

509

1.69

6.60

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

270

1386

1.41

6.58

1.7

1.6

nmol/l

4.5

9.0

0.54

230

1153

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

210

2.10

6.53

1.3

1.2

—

(36660697) Celiac disease serology panel - Serum

3823

25382

1.10

6.42

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.47

6.33

1.2

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

104

435

1.73

6.27

2.4

2.9

u/l

2133.4

1744.4

0.18

395

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.02

6.27

1.0

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

227

1142

1.44

6.21

2.1

2.7

ug/l

1.3

1.2

0.18

213

1074

(3042951) Complement C1q Ab [Units/volume] in Serum

122

2.43

6.16

1.2

1.3

u/ml

31.6

16.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

422

2351

1.30

6.09

1.1

—

(3016879) Cocaine [Presence] in Urine

2027

13054

1.13

6.07

3.6

2.0

—

(3028717) Thiamine [Mass/volume] in Blood

287

1.89

6.04

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

246

1263

1.41

6.03

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

313

1673

1.35

6.02

1.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

247

1.96

6.02

1.2

mg/l

48.8

46.9

0.11

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.94

5.98

3.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

230

1169

1.42

5.97

1.0

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

362

1981

1.32

5.95

3.7

3.3

nmol/l

156.8

124.6

0.89

355

1951

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

5.79

5.89

1.1

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

119

526

1.64

5.89

4.6

4.9

u/l

50.6

58.8

0.27

200

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

139

2.29

5.83

1.0

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.56

5.70

1.2

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

364

1.75

5.57

1.5

1.3

titre

308.3

132.6

—

(3044009) aPTT.lupus sensitive (LA screen)

270

1.88

5.54

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

100

431

1.68

5.48

1.6

—

(3001729) Color of Synovial fluid

206

2.00

5.45

1.5

1.6

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

159

1687

0.68

5.43

1.3

1.4

nmol/l

29.1

31.5

0.56

141

1543

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

203

2.00

5.32

1.1

u/l

10.8

9.2

0.30

203

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

213

1.97

5.31

1.3

1.5

46.7

35.8

1.15

141

(3028468) Fragments [Presence] in Blood by Light microscopy

5.68

5.31

2.5

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

174

2.08

5.29

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

317

1736

1.32

5.25

1.1

nmol/l

4.9

5.0

0.02

326

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

302

2873

0.76

5.25

1.4

1.3

pmol/l

95.4

113.5

0.21

143

856

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

601

0.48

5.21

1.2

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

114

2.35

5.21

1.0

u/ml

0.1

0.31

(3019832) Treponema pallidum Ab [Presence] in Serum

4164

32328

0.93

5.18

1.7

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

186

2.02

5.13

1.2

1.6

12.4

12.6

0.02

133

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

429

1.65

5.10

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

3.16

5.10

1.4

1.3

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

6.03

5.08

1.0

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

182

917

1.44

5.04

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

193

1.99

4.99

4.3

4.9

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

174

2.04

4.94

1.6

1.7

0.7

0.06

134

(37019676) Renin [Units/volume] in Plasma --supine

2.85

4.91

1.0

1.1

mu/l

77.8

48.0

0.30

(4146454)

536

3161

1.23

4.89

2.6

2.8

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

156

2.09

4.84

1.1

1.4

3.6

0.9

1.43

101

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

4.27

4.70

1.1

1.4

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

163

2.04

4.69

1.2

1.1

u/l

67.8

91.0

0.19

130

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

357

1.68

4.65

2.6

2.3

u/field

0.6

0.02

357

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

130

2.17

4.63

1.0

u/ml

0.1

0.2

0.70

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

179

1.98

4.61

1.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

46642

334689

1.06

4.60

29.7

13.3

umol/l

83.1

75.7

188.14

46622

334535

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

129

620

1.51

4.57

2.2

2.6

—

(3024316) Viscosity of Plasma

131

2.15

4.55

2.2

1.7

mpas

1.6

1.7

0.30

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2932

19554

1.09

4.53

1.3

au/ml

38.1

50.5

1.91

845

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2186

17342

0.91

4.52

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

201

1.91

4.49

1.1

1.2

26.5

19.0

0.29

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

161

2.02

4.48

1.2

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

211

1116

1.37

4.47

2.1

2.0

mg/l

8.1

9.4

3.18

172

890

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

100

2.31

4.42

1.1

pmol/l

185.5

214.3

0.15

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

136

667

1.48

4.39

1.1

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

220

1176

1.35

4.37

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

420

2446

1.24

4.36

1.1

mg/l

314.3

261.2

1.56

364

2145

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

158

2.01

4.35

1.1

u/l

2.2

3.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

110

2.24

4.35

1.2

1.3

u/field

1.1

1.2

0.47

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

110

2.24

4.35

11.1

9.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

173

891

1.41

4.31

1.8

1.7

au/ml

54.3

138.9

3.34

111

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.24

4.29

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

297

1665

1.29

4.24

1.6

1.5

ug/l

10.2

7.7

0.72

266

1519

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.44

4.19

1.4

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

327

1.66

4.05

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

2121

14019

1.10

4.04

3.5

2.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

431

2544

1.23

3.99

1.2

1.1

mg/l

49.0

41.4

0.74

358

2132

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

198

1059

1.35

3.96

1.1

—

(3021374) Sirolimus [Mass/volume] in Blood

3.49

3.95

12.1

8.4

ug/l

6.9

7.8

0.56

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

305

1734

1.27

3.94

2.2

2.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

229

2163

0.76

3.90

1.3

g/l

1.4

1.5

0.55

125

(3028300) Cannabinoids [Presence] in Urine

2135

14145

1.10

3.88

3.6

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1969

15573

0.91

3.87

1.5

1.4

iu/l

24.5

27.3

3.73

1639

13381

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

846

7020

0.87

3.85

1.5

1.4

pmol/l

147.5

130.2

0.47

825

6850

(3017400) Magnesium [Moles/volume] in Urine

2.52

3.83

1.1

1.3

mmol/l

3.2

3.0

0.09

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

523

4503

0.84

3.81

1.3

mmol/l

7.6

7.1

2.11

385

3223

(3036071) Salmonella sp Ab [Titer] in Serum

183

975

1.36

3.78

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.62

3.76

1.5

1.3

—

(3027008) Opiates [Presence] in Urine

2126

14106

1.09

3.76

3.5

2.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

119

1233

0.70

3.72

1.6

1.4

—

(3015183) Erythrocyte sedimentation rate

176

1711

0.74

3.71

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

206

1121

1.33

3.71

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

153

1.94

3.70

1.2

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

2.93

3.70

6.4

7.6

e6/l

7772.0

485.1

0.44

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3177

21448

1.08

3.67

2.4

au/ml

24.1

23.8

0.05

126

1352

(3017509) Phencyclidine [Presence] in Urine

382

1.57

3.65

2.1

1.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

247

1388

1.29

3.55

1.1

97.4

97.8

0.07

214

1095

(3025130) Human papilloma virus identified in Specimen

506

4338

0.84

3.54

1.8

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2709

21053

0.93

3.54

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

187

1.82

3.52

1.3

1.4

umol/24h

368.4

326.3

0.45

187

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

335

1.60

3.51

1.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

141

1.95

3.50

1.2

1.3

—

14622.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

172

1.85

3.49

1.0

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.64

3.48

1.4

1.3

e6/l

37.9

67.7

0.51

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

183

1.82

3.46

1.3

pmol/l

15.0

17.4

0.53

157

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

337

1.59

3.43

3.6

2.9

mg/l

18.5

23.7

3.17

319

(4027681)

332

1943

1.24

3.40

1.3

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.34

3.33

1.4

1.6

ug/l

120.6

126.7

0.04

(3013336) Amino acids [Identifier] in Serum or Plasma

119

2.01

3.31

3.1

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5405

37238

1.06

3.31

11.4

6.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

329

1.58

3.31

3.7

3.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

290

1.62

3.29

1.2

1.3

mmol/l

6.5

6.1

0.18

139

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

111

559

1.44

3.24

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

101

2.08

3.19

1.2

1.4

nmol/l

753.6

434.4

1.55

101

(3009677) Dengue virus Ab [Presence] in Serum

106

2.05

3.18

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

334

1.56

3.12

1.7

mg/l

1.7

0.08

278

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8718

60857

1.04

3.08

1.6

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

291

1701

1.24

3.06

1.1

u/l

1.1

1.00

123

774

(3027974) Hepatitis B virus e Ag [Presence] in Serum

186

1.75

3.03

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

193

1077

1.30

2.99

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

236

1.66

2.99

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

119

618

1.39

2.96

1.1

umol/24h

0.7

3.0

0.51

303

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.24

2.92

1.7

1.6

nmol/l

489.2

192.1

1.03

(3022689) Creatine [Moles/volume] in Urine

157

855

1.33

2.91

1.5

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1091

7110

1.11

2.88

2.0

1.9

pmol/l

194.0

199.9

0.91

1031

6776

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

256

1.61

2.86

1.3

nmol/l

15.3

15.5

0.03

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

320

1907

1.21

2.83

1.1

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

305

1810

1.22

2.82

1.0

ng/l

272.9

345.1

2.38

215

1296

(3027944) Amphetamines [Presence] in Urine

2067

13886

1.08

2.81

3.3

1.9

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.30

2.81

1.9

1.6

nmol/l

537.8

219.6

0.88

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

2.23

2.78

2.0

1.6

umol/l

242.4

288.3

0.18

(3000285) Sodium [Moles/volume] in Blood

345

1.51

2.75

1.3

1.2

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.26

2.72

1.2

1.0

g/l

0.5

0.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

477

1.43

2.70

1.6

1.8

pmol/l

48.4

61.5

0.49

394

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

5.06

2.60

1.1

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

5.06

2.60

1.1

1.0

—

(3041184) Isoniazid [Presence] in Urine

2.89

2.60

2.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

304

1823

1.21

2.57

1.0

ng/l

722.4

747.4

0.44

203

1265

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

181

1025

1.28

2.57

1.3

1.2

113.4

111.0

0.49

159

925

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.52

2.56

1.1

1.2

—

(3051339) Copper [Moles/volume] in Blood

153

1.75

2.54

1.2

umol/l

16.6

16.8

0.08

133

(3006462) Nitrate [Presence] in Urine

246

1447

1.23

2.52

3.3

3.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

304

1827

1.20

2.52

1.0

ng/l

42.5

42.2

0.02

206

1289

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.96

2.51

1.3

1.1

nmol/l

332.4

252.0

0.67

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

604

4960

0.88

2.50

1.5

nmol/l

0.4

0.49

452

3889

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

218

0.43

2.48

1.1

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.95

2.46

2.7

2.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.21

2.35

1.1

1.0

g/l

0.0

0.1

—

(3011048) Pyruvate [Moles/volume] in Blood

202

1.61

2.32

1.4

umol/l

90.1

81.8

0.51

185

(3034092) Cytoplasmic Ig cells/100 cells in Blood

383

1.44

2.32

15.9

6.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

3.01

2.32

1.0

—

(1002224) Polysomnography panel

1778

13771

0.93

2.25

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.27

2.23

1.1

—

(4281824)

494

3130

1.14

2.18

1.2

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

147

831

1.28

2.17

1.6

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

172

1.64

2.17

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

283

1721

1.19

2.12

1.9

2.0

ug/l

3.7

0.01

240

1511

(3003694) ABO and Rh group [Type] in Blood

12612

89185

1.03

2.11

1.5

—

(3025577) Chromium [Mass/volume] in Blood

275

1670

1.19

2.10

1.9

2.1

ug/l

2.3

0.06

212

1407

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.65

2.08

1.2

—

(36303858) Crystals [Presence] in Urine

2.41

2.06

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

129

723

1.29

2.06

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

150

858

1.26

2.04

1.6

ug/l

10.2

8.9

1.96

150

858

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

220

0.49

2.04

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

39515

283661

1.03

2.03

6.7

5.4

mmol/mol

41.2

39.2

231.04

36554

263729

(3036180) Methadone [Presence] in Urine

1.99

1.97

1.7

3.2

—

(4211845)

260

1584

1.19

1.95

3.3

2.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

453

2882

1.14

1.93

1.2

1.3

mmol/l

11.9

0.01

187

685

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

3.94

1.92

1.0

1.2

—

(3027874) Urate [Moles/volume] in Urine

1.81

1.90

1.2

1.0

mmol/l

1.5

8.3

0.52

(40761511) CBC panel - Blood by Automated count

45807

329633

1.03

1.89

24.1

10.9

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

246

1500

1.19

1.84

1.1

u/ml

9.2

9.8

0.10

248

(3043614) Bacteria identified in Aspirate by Culture

4.52

1.83

1.0

1.1

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

4.52

1.83

2.6

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5300

37053

1.04

1.79

4.5

4.3

31.9

32.1

0.88

3898

25545

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.60

1.75

1.1

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

550

1.30

1.74

1.6

1.5

nmol/l

0.2

1.66

395

(3021706) Oxygen [Partial pressure] in Arterial cord blood

284

1.43

1.73

1.0

kpa

3.7

3.5

0.12

245

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

734

4836

1.10

1.72

1.4

u/l

24.4

26.3

0.98

601

3982

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.79

1.70

2.0

2.1

—

(44813793)

369

2340

1.14

1.69

1.1

—

(40762814) Titanium [Mass/volume] in Blood

479

1.31

1.65

2.2

2.3

ug/l

3.8

3.7

0.10

168

(3013247) Albumin in CSF/Albumin in Serum or Plasma

120

690

1.26

1.63

1.1

mg/g

7.9

6.7

0.96

112

655

(40768793) Breast Pathology biopsy report

850

6674

0.92

1.63

1.4

1.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

222

1.47

1.62

1.0

1.1

u/ml

44.0

33.8

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

222

1.47

1.62

1.0

1.1

u/ml

24.1

25.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

187

1.51

1.61

1.5

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

186

1123

1.20

1.60

1.3

1.2

g/l

0.3

0.89

153

901

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

596

3904

1.10

1.60

1.6

—

(3032641) Amino acids panel - Urine

2.02

1.54

1.6

1.2

—

(3004959) Base excess in Arterial cord blood by calculation

292

1.39

1.52

1.0

mmol/l

-2.1

-2.4

0.09

(3006598) pH of Arterial cord blood

292

1.39

1.52

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

292

1.39

1.52

1.0

kpa

7.4

7.2

0.21

253

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

138

1.57

1.50

1.6

1.5

u/l

0.2

0.12

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.90

1.49

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

170

1465

0.84

1.48

1.9

1.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

300

1.37

1.48

1.0

1.1

umol/24h

1.8

2.9

0.42

300

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

223

0.58

1.48

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.29

1.44

1.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

3.29

1.44

1.0

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.95

1.41

1.1

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.15

1.41

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.15

1.41

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.15

1.41

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.15

1.41

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.15

1.41

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.15

1.41

2.0

—

(3049233) Organic acids panel - Urine

1.81

1.39

1.4

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

429

1.30

1.39

1.1

u/ml

0.3

0.08

265

(3021387) Prolactin [Units/volume] in Serum or Plasma

1718

11797

1.05

1.36

1.7

1.6

mu/l

336.0

306.3

2.01

1547

10694

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

195

1.45

1.36

1.2

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.96

1.34

1.2

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

131

1.55

1.33

1.2

1.1

u/l

290.2

365.6

0.26

112

(3036005) Urine sediment comments by Light microscopy Narrative

2.17

1.32

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

528

4185

0.91

1.32

1.5

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

203

1262

1.16

1.30

2.9

3.4

mg/l

8.2

8.0

0.16

155

1009

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.76

1.29

1.0

1.4

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

228

1.40

1.28

1.3

1.4

u/ml

7.2

6.7

0.03

193

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

2.10

1.28

1.1

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

2.10

1.28

1.1

1.3

—

(4034850)

1430

9805

1.06

1.23

13.8

8.7

—

(3034614) HLA Ag [Interpretation]

1.75

1.21

1.3

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

186

1159

1.16

1.19

2.6

2.8

au/ml

148.5

153.9

0.05

148

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

405

0.73

1.18

1.1

1.3

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

1.18

0.0

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10999

80848

0.98

1.16

1.7

1.6

mmol/l

1.5

1.4

32.35

9344

68060

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.64

1.15

1.1

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

2.58

1.15

1.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

2.58

1.15

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

129

1105

0.84

1.13

1.0

—

(3013762) Body weight Measured

120

1.51

1.10

1.1

—

(44806420)

125

760

1.19

1.09

2.0

2.4

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

150

1.45

1.09

1.5

1.6

ng/l

191.8

203.3

0.31

129

(1617658) Protocol used for examination of sentinel lymph nodes

272

2202

0.89

1.08

1.1

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.85

1.07

1.1

—

(4133840)

146

905

1.17

1.03

1.3

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.62

1.01

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1463

10104

1.05

1.00

1.3

miu/ml

217.3

226.2

0.37

521

4754

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.67

0.99

1.5

1.4

nmol/l

164.7

126.1

—

(3022670) pH of Venous cord blood

1.56

0.98

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

179

1.37

0.96

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.95

0.95

1.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

409

1.24

0.94

2.8

2.6

pmol/l

76.9

71.0

0.12

357

(3036312) Salmon IgE Ab [Units/volume] in Serum

199

1.34

0.93

1.1

u/ml

1.4

1.7

0.14

149

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.58

0.89

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

107

902

0.86

0.84

2.8

3.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

241

1.29

0.83

1.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

107

901

0.86

0.83

5.6

6.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

46397

336324

0.98

0.81

15.6

9.2

u/l

27.0

26.8

0.71

45178

324668

(3015076) Soybean IgE Ab [Units/volume] in Serum

235

1878

0.90

0.81

1.1

1.0

u/ml

0.5

0.8

0.39

277

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.76

0.80

1.0

1.1

titre

1112.0

2358.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

267

1756

1.10

0.80

1.4

1.3

umol/l

4.3

4.9

2.17

240

1616

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.70

0.80

1.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.51

0.79

3.8

5.9

mmol/l

0.2

0.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

399

1.21

0.79

2.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

155

991

1.13

0.78

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.26

0.77

1.0

1.1

umol/l

12.6

18.7

—

(3008898) HLA-B27 [Presence]

1469

11024

0.96

0.75

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1177

8161

1.04

0.75

1.9

1.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2220

15579

1.03

0.74

1.1

titre

107.4

228.7

3.43

414

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

571

0.84

0.73

1.6

1.7

ug/l

2.5

3.7

0.47

344

(3020123) Porphyrins [Interpretation] in Serum or Plasma

176

1.31

0.73

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

895

6171

1.05

0.73

1.4

1.3

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.01

0.72

1.4

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

1.59

0.71

1.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

177

1.31

0.71

1.0

u/ml

1.2

0.4

0.71

159

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

587

4021

1.06

0.64

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.61

0.61

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.49

0.60

1.2

1.4

mmol/24h

1.5

2.1

0.80

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

354

0.82

0.59

1.0

u/ml

14.8

1.9

0.43

193

(3014599) Egg white IgE Ab [Units/volume] in Serum

271

2111

0.93

0.59

1.1

u/ml

5.2

5.3

0.01

572

(3009542) Hematocrit [Volume Fraction] of Blood

40491

293623

0.99

0.58

27.4

12.4

38.9

40.2

157.58

28085

219916

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

448

1.16

0.58

1.1

1.0

ug/l

77.8

82.8

0.41

367

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

134

0.70

0.57

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

483

1.15

0.56

1.6

nmol/l

5.0

6.3

0.75

463

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.37

0.56

1.0

u/ml

0.1

0.3

—

(3049242) von Willebrand panel - Platelet poor plasma

1.37

0.56

1.4

1.6

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.61

0.53

1.3

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

394

0.84

0.51

2.8

1.2

mmol/l

8.4

6.9

2.01

125

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1448

10185

1.03

0.49

1.8

1.7

nmol/l

39.4

40.6

1.05

1404

9954

(3003157) Bacteria [#/volume] in Mother's milk

0.60

0.46

5.4

7.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

348

0.85

0.43

1.1

1.0

u/ml

2.7

0.6

0.39

187

(3034707) Cochineal extract IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.2

—

0.8

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.51

0.41

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

597

4156

1.04

0.40

2.0

2.2

umol/l

6.9

7.5

0.36

448

3049

(3020874) Milk IgE Ab [Units/volume] in Serum

283

2162

0.95

0.40

1.1

u/ml

2.5

2.3

0.07

100

686

(3010726) Horse dander IgE Ab [Units/volume] in Serum

810

5672

1.03

0.40

1.1

u/ml

2.5

2.3

0.18

233

1422

(42870560) Thyrotropin [Units/volume] in Cord blood

362

1.14

0.39

1.0

mu/l

10.9

8.7

1.54

310

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

207

1403

1.07

0.39

1.2

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

241

1.17

0.38

1.0

u/ml

2.1

1.6

0.17

167

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

208

1.18

0.38

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2982

21891

0.98

0.37

1.2

iu/ml

133.8

143.1

0.59

975

8285

(3018001) Oat IgE Ab [Units/volume] in Serum

218

0.83

0.37

1.0

u/ml

0.2

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.65

0.36

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

145

975

1.08

0.36

1.1

1.0

u/ml

8.5

11.4

0.64

127

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

177

0.82

0.34

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

604

4513

0.97

0.34

1.1

u/ml

3.9

5.4

1.77

297

1891

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1279

9044

1.02

0.34

1.1

u/ml

6.8

5.5

0.34

131

1228

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

387

2915

0.96

0.33

4.4

4.8

u/ml

109.7

106.4

0.03

100

912

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.28

0.33

1.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

205

1.16

0.32

1.1

u/ml

2.0

1.9

—

(4038314)

268

0.86

0.31

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

769

5708

0.97

0.30

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

126

1.21

0.30

1.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.27

0.30

1.1

—

(3003577) Lead [Moles/volume] in Blood

256

1.13

0.28

1.5

1.4

umol/l

0.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

521

3882

0.97

0.27

1.1

1.0

u/ml

0.3

0.5

1.31

161

849

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.23

0.27

1.6

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1707

12536

0.98

0.26

2.5

2.3

u/l

5394.3

5855.7

0.23

601

4879

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.28

0.25

1.5

1.0

2.6

0.02

(3014133) Dog dander IgE Ab [Units/volume] in Serum

649

4807

0.98

0.24

1.1

u/ml

5.3

4.5

0.35

305

1910

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

389

0.91

0.23

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

144

1.15

0.22

1.3

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

4.9

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.22

0.0

1.3

—

2.2

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.21

0.0

1.3

—

(40758358) Immune stain study

131

1.16

0.21

1.0

—

(46235479) Bilirubin fractions panel [Moles/volume] - Serum or Plasma

0.00

0.21

0.0

1.3

—

88.8

—

(40762887) Creatinine [Moles/volume] in Blood

1.24

0.20

1.5

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

125

859

1.05

0.20

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

742

5261

1.02

0.20

1.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.21

0.20

1.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.19

0.19

1.1

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.21

0.18

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

293

1.09

0.17

1.7

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2153

15720

0.99

0.17

3.6

3.2

u/ml

56.4

50.1

0.65

2082

15169

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.19

0.17

1.1

pmol/l

431.6

357.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

164

1142

1.04

0.17

1.3

1.4

mu/l

607.8

726.6

0.43

149

1083

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

162

1216

0.96

0.16

1.8

1.9

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

281

1.08

0.15

1.0

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

1.16

0.15

1.1

1.4

—

(3007700) Barley IgE Ab [Units/volume] in Serum

147

0.89

0.15

1.1

1.0

u/ml

0.3

9.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1625

11866

0.99

0.15

1.8

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

166

1161

1.03

0.14

1.3

1.4

72.7

72.9

0.04

151

1102

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

402

1.06

0.14

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

858

6122

1.01

0.14

1.1

u/ml

5.6

5.2

0.32

503

3194

(3044336) Cobalt [Moles/volume] in Urine

0.83

0.14

2.4

nmol/l

10.8

30.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

243

0.92

0.13

1.0

1.1

u/ml

0.7

0.9

0.24

148

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

948

6773

1.01

0.13

1.2

1.1

u/ml

2.5

1.6

1.04

455

2801

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

245

1728

1.03

0.13

2.3

1.9

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

221

1.08

0.12

3.4

2.9

pmol/l

1468.0

83.7

0.45

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

435

0.95

0.12

1.1

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

486

0.95

0.12

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

255

1885

0.98

0.12

5.9

6.7

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.88

0.11

1.0

u/ml

1.2

0.8

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

248

0.93

0.11

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

667

0.96

0.10

1.9

—

(3020650) Glucose [Presence] in Urine

121

849

1.03

0.10

1.6

1.4

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

210

0.93

0.10

1.0

u/ml

1.2

1.5

0.13

152

(40759632) Porphyrins [Mass/mass] in Stool

1.13

0.10

1.2

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

113

0.90

0.10

1.0

u/ml

0.9

0.1

—

(3022475) Manganese [Moles/volume] in Blood

202

0.93

0.09

1.2

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

146

1030

1.02

0.09

1.1

u/ml

2.3

6.6

0.74

612

(3051101) Glucose [Moles/volume] in Cord blood

488

1.04

0.08

5.3

5.9

—

(3040794) Aluminum [Moles/volume] in Urine

0.79

0.08

1.0

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.77

0.08

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

332

1.05

0.08

1.0

u/ml

0.2

0.06

199

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

311

0.95

0.08

1.0

u/ml

0.2

0.4

0.48

170

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.82

0.07

1.2

1.1

nmol/24h

59.9

105.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

101

750

0.97

0.07

2.1

2.7

ng/l

111.5

113.2

0.04

405

(3033942) Copper [Moles/time] in 24 hour Urine

141

1.08

0.07

1.4

1.2

umol/24h

2.1

0.6

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.10

0.07

1.0

u/ml

0.0

0.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.07

0.07

1.7

2.4

mu/l

1.4

2.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

631

0.97

0.06

1.1

u/ml

8.5

6.6

0.17

453

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

212

0.95

0.05

1.1

u/ml

6.1

8.0

0.24

139

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

238

1738

0.99

0.04

1.3

1.4

mmol/l

5.8

5.7

1.13

217

1645

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.09

0.04

1.0

u/ml

0.1

0.9

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

108

0.94

0.03

1.0

u/ml

1.7

0.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

619

1.02

0.03

1.2

1.3

u/ml

0.1

5.8

3.00

147

(3045683) HLA typing for celiac disease panel - Blood or Tissue

277

1989

1.01

0.03

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

810

5843

1.00

0.02

1.1

u/ml

1.1

0.00

400

2538

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

654

4717

1.00

0.01

1.1

u/ml

3.3

3.0

0.19

253

2324

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

370

1.02

0.01

1.1

u/ml

4.6

3.0

0.26

287

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

421

1.01

0.01

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

366

0.99

0.00

1.1

u/ml

3.1

5.8

0.57

280

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

100

1.01

0.00

1.1

1.0

—

(3001556) Androgen free Index in Serum or Plasma

336

1.01

0.00

1.5

1.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

155

1.03

0.00

1.1

1.0

u/ml

0.2

12.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

120

865

1.00

0.00

2.6

2.9

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

192

1.02

0.00

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

233

1683

1.00

0.00

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

343

1.01

0.00

1.1

1.0

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3039179) Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid

0.00

0.0

1.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.98

0.00

1.2

1.1

mmol/24h

147.9

148.6

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.95

0.00

1.0

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.84

0.00

1.0

1.3

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.95

0.00

2.0

2.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: J10_PNEUMONAS – Pneumonia, organism unspecified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Pneumonia, organism unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Pneumonia, organism unspecified (J10_PNEUMONAS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints